{"slide_id": "TCGA-VQ-A8PD-01Z-00-DX1.A9B601CB-83AA-4F0C-BB6D-DD88455FDEE9", "reference": "Stomach (Body) moderately differentiated adenocarcinoma with metastasis in lymph nodes. The carcinoma extends from the esophagogastric junction to duodenum, measuring 8.7x6.5cm macroscopically. Perineural and angiolymphatic invasion present with moderate peritumoral desmoplasia and sparse peritumoral lymphocitary infiltrate. The surgical margins are uninvolved by neoplasia. Spleen congested, with one metastasis in the 11p lymph node and five of six lymph nodes involved by metastatic carcinoma in the 8a node. One metastasis of carcinoma is also present in the 12a lymph node. Margin uninvolved by neoplasia. Pathological staging is pT3 pN3b.", "prediction": "1-mermer-immunology-human total-1-human-1\u00a0mer-mer-1 total\u00a0immunopmer-5-mer\u00a0immunology\u00a0\u00a0\u00a0house\u00a0\u00a0immunologic\u00a0\u00a01-immunop\u00a0\u00a0mer\u00a0\u00a0human-immunologic-1.1-4\u00a0immun\u00a0\u00a05\u00a0\u00a0total-human\u00a0\u00a0ph\u00a0\u00a0d-1 or greater\u00a0immunotroro-gen-protein-house-immunot\u00a0\u00a0duro-protein targeted-immunologically topped-house toro-d-4 tomer- or\u00a0\u00a07\u00a0\u00a0-\u00a0\u00a0to\u00a0\u00a0un\u00a0\u00a0sp\u00a0\u00a0other\u00a0\u00a02\u00a0\u00a0cell\u00a0\u00a0targeted\u00a0\u00a03\u00a0\u00a0protein\u00a0\u00a04\u00a0\u00a0end\u00a0\u00a0one-immun\u00a0immun-\u00a01\u00a0\u00a0omb\u00a0\u00a0we\u00a0\u00a010\u00a0\u00a0trans\u00a0immunotr\u00a0\u00a0polymer-\u00a0immunone-\u00a0du\u00a0\u00a0or\u00a0\u00a0(\u00a0\u00a0\u00a0\u00a0Western\u00a0immunother\u00a0dumer-un\u00a05-immun-mer \u00a0\u00a00\u00a0\u00a0\u20091-cell\u00a0immunmer\u00a0du-\u00a0sp-\u00a0mer targeted\u00a0immun"}
{"slide_id": "TCGA-ET-A39S-01Z-00-DX1.078746BC-33B7-47A2-A6D8-F5B2E6180E30", "reference": "Specimen type: Total thyroidectomy\r\nTumor site: Left lobe\r\nHistologic type: Papillary carcinoma\r\nTumor size: 1.0 CM (unifocal)\r\nLymph Nodes: Negative for tumor\r\nExtent of invasion:\r\nPrimary Tumor: pT1 (size <2 cm, limited to thyroid)\r\nRegional Lymph Nodes: pNO (No regional lymph node metastases)\r\nDistant Metastasis: pMx (Cannot be assessed)\r\nMargins: Uninvolved. Distance of invasive carcinoma from nearest margin: <1 mm (anterior and posterior)\r\nVenous/Lymphatic Invasion: Absent\r\nAdditional Pathologic Findings: None identified.", "prediction": "-immunologic-immunology-protein-total\u00a0in\u00a0total\u00a0protein-1-protein\u00a0immunop\u00a0gen\u00a0total-immunopgen\u00a01\u00a0\u00a0immunologic\u00a0immun\u00a0\u00a0\u00a0protein\u00a0\u00a0un\u00a0immunology\u00a0\u00a0pregen\u00a0\u00a01-1\u00a0immunot\u00a0\u00a0total immunop\u00a0\u00a0urvin\u00a0\u00a0targeted\u00a0\u00a0gen-1 greater\u00a0\u00a0human-immunologically\u00a0\u00a0inveregen-total-protein total-in\u00a0gen1-pregen-protein immunotr\u00a0\u00a0v\u00a0premer-immunotr1-immun immunotro\u00a0\u00a0vin\u00a0total\u2009\u00a0\u00a05\u00a0\u00a0tot\u00a0\u00a03\u00a0\u00a0more\u00a0\u00a0(\u00a0\u00a0drug\u00a0\u00a0-\u00a0\u00a0clinically\u00a0\u00a0we\u00a0immun-immun\u00a0immun immun\u00a0\u00a0pathologic\u00a0\u00a0house\u00a0\u00a0compar\u00a0\u00a0du\u00a0\u00a0prof\u00a0\u00a0\u2009\u00a0immunimmun\u00a0protein targeted\u00a0immunove\u00a0\u00a0mer\u00a0\u00a0con\u00a0\u00a0pro\u00a0immungen\u00a0immunother\u00a0\u00a0\u00a0protein immunologic\u00a0\u00a02\u00a0\u00a0terminal\u00a0\u00a00\u00a0\u00a0ie\u00a0immunun\u00a0protein\u2009gen\u00a0genologic\u00a0proteinvin\u00a0immunvin\u00a0gengen-immunimmunologicologic\u00a0total"}
{"slide_id": "TCGA-85-A511-01Z-00-DX1.24345C5F-BDC2-4D9D-BAE5-686B4C8C66DE", "reference": "Filtered Report:\r\n\r\nSpecimen type: Lobectomy. Tumor site: Lung. Tumor size: 6 x6x6cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Visceral pleura. Lymph nodes: 1/3 positive for metastasis (Intrathoracical 1/3).", "prediction": " total-immunology-protein-1-mer-total-human-1\u00a0ph\u00a0total-protein targeted-immunologic-protein\u00a0\u00a0\u00a01-ph\u00a0immunology\u00a0\u00a0un\u00a0ph-1\u2009\u00a0\u00a0du\u00a0\u00a0phun\u00a0\u00a0other\u00a0\u00a0total\u00a0\u00a0protein-\u00a0\u00a0immunologic\u00a0\u00a0targeted-1 targeted\u00a0\u00a0-\u00a01\u00a0\u00a0pr\u00a0other-drug-gen-targeted-targeted total\u00a0du-immunore-targeted\u00a0immunod-immunotrogen-immunop\u00a0\u00a0in\u00a0\u00a05\u00a0\u00a0to\u00a0\u00a0house\u00a0\u00a07\u00a0\u00a0drug-1 or\u00a0\u00a0tur\u00a0\u00a0we-\u00a0pr-\u00a0protein\u00a0targeted\u00a01\u2009-\u00a0immunother\u00a0prur\u00a0\u00a03\u00a0\u00a0ne\u00a0\u00a04-\u00a0ph\u2009\u00a0otherape\u00a0\u00a0or\u00a0\u00a0gen\u00a0\u00a0otr\u00a0\u00a0sp\u00a0\u00a0ur\u00a0immun\u00a0\u00a0\u2009du\u00a0protein to\u00a0immunotr\u00a0pr\u2009\u00a0duro-\u00a0duct\u00a0\u00a0cell\u00a0\u00a0mer\u00a0\u00a0trans\u00a0\u00a00-\u00a0gen-\u00a0otherother\u00a0photr\u00a0dugen-1 disease-immunother-\u00a0-immun-\u00a0total total\u2009\u00a0protein"}
{"slide_id": "TCGA-AG-3901-01Z-00-DX1.3deb3ae7-a068-4d4b-868d-5507582c5e82", "reference": "Moderately differentiated mucinous adenocarcinoma of the colorectal type was identified in the rectosigmoidal resection material. The tumor measured 4 cm in diameter, with circumscribed infiltration of perirectal fatty tissue and two regional lymph node metastases identified. Tumor-free colon resection margins were observed, with a minimum distance of 1 cm from the circumferential resection margin on histological section. Tumor-free mesenteric resection margin was also observed. The tumor stage was identified as pT3, pN1 (2/20) pMX, G2, L1, V0, locally R0.", "prediction": "-protein-nanopnanornanor protein-protein\u00a0we\u00a0decor protein,\u00a0\u00a0\u00a0cell\u00a0we\u2009decor\u00a0decaperob and\u00a0\u00a0more\u00a0dec\u00a0decavor-decapedecapeaperob-dec\u00a0moremore\u00a0more-type-protein,\u00a0more fully-type and\u00a0protein-type,\u00a0decdecapeptor-drug-protein fully-protein and\u00a0decmoremoremore-decav\u00a0decatmoremoremoremorevin\u00a0decade\u00a0decotrmoremore Herein Herein Herein\u00a0\u00a0\u00a0protein\u00a0\u00a0decaptor\u00a0\u00a0\u223c\u00a0\u00a0qu\u00a0\u00a0\u2009\u00a0\u00a0vinvin\u00a0\u00a0Trans\u00a0dec Therape\u00a0dec\u2009decape\u00a0\u00a0pro\u00a0dec10\u00a0more\u2009dec\u00a0\u00a0than\u00a0\u00a0we fully\u00a0decrug\u00a0dec5\u00a0\u00a0~\u00a0\u00a0ph\u00a0decvin\u00a0\u223c\u2009\u00a0dec-decdec\u00a0\u223c\u223c\u00a0morequ\u00a0dec7\u00a0dec Nan Nan\u00a0\u00a07\u00a0morevin\u2009dec\u2009\u2009\u00a0\u2009\u2009dec Thermore\u00a0\u00a04\u00a0\u00a0T\u00a0\u00a0nan\u00a0\u00a08\u00a0dec\u2005dec\u00a0\u2009\u223c\u00a0\u2009decdec Ther\u00a0\u00a0cell\u2009\u00a0\u223cdec\u00a0qu\u2009"}
{"slide_id": "TCGA-AA-3949-01Z-00-DX1.23748e80-0d7e-4238-8b29-f74cddae8596", "reference": "Filtered report: A poorly differentiated, partially mucinous adenocarcinoma of the colorectal type was found in a right hemicolectomy preparation. The tumor is located 0.5 cm aborally to Bauhin's valve and encircling the intestinal wall at a length of 5 cm, with invasive spreading within all intestinal wall layers to the subserosa. Three of nineteen lymph nodes display metastasis, not extending across the capsules. Stage of tumor is therefore: pT3, pN1 (3/19) LO V0; G3 R0.", "prediction": "-protein-protein\u00a0wequ protein-cell-decor protein- and\u00a0retret-protein,\u00a0\u00a0\u00a0cell-cell\u00a0more\u00a0decor-dec\u00a0dec\u00a0nan\u00a0dec-dec-10-dec,\u00a0~\u00a0protein- and\u2009~\u00a0b-protein and\u00a0more-decaperob-type-protein type-type,\u00a0more fully-decav protein-protein fully-type and\u00a0decavor-protein kinase\u00a0decaperet-decret-type\u00a0more\u00a0cell\u00a0decretor-more\u00a0moremore\u00a0we\u00a0we\u2009\u2009\u00a0\u00a0decade\u00a0dec\u2009\u00a0more\u2009dec\u00a07\u00a0\u00a0\u2009\u00a0dec5\u00a0\u00a0\u223c\u00a0\u00a0morevin\u00a0dec7\u00a0dec10\u00a0\u00a07-dec5\u2009\u00a0\u223c\u2009\u00a0qu\u00a0decotrmore\u00a0\u00a05\u00a0decR\u00a0\u00a0~\u2009\u00a0cell\u2009dec\u2009dec5-dec\u2009\u2009\u2009-\u00a0\u00a04\u00a0\u00a0than\u00a0\u00a0mer\u00a0decdec\u00a0\u00a0qu\u2009\u00a0\u2009\u2009dec-\u00a0dec8\u00a0\u00a0vin\u00a0\u00a0-\u00a0\u2009decape\u00a0\u00a08\u00a0\u2009\u223c\u00a0\u223c\u223c\u00a0decaptor\u00a0\u00a0ph\u00a0\u00a0ret\u00a0\u00a0"}
{"slide_id": "TCGA-DU-A76K-01Z-00-DX1.8620CC08-5A61-4B36-8D4A-078348B5E345", "reference": "Pathological diagnosis: Brain biopsy, right parieto-occipital lobe revealing Oligodendroglioma (grade B) with a MIB-1 index of 6%. Gross pathology: A 1.2 x 0.6 cm tissue fragment with focally hemorrhagic, gray-white soft brain parenchyma 1.5 x 1.2 x 1 cm in aggregate was observed. Microscopic analysis revealed a hypercellular oligodendroglioma involving both the cortex and the white matter, with areas of prominent nuclear pleomorphism and hyperchromasia, clusters of calcification, and focal areas of endothelial hyperplasia. No necrosis was identified. Tissue committee code: TC1. Clinical history and pre-op Dx were not provided.", "prediction": "\u00a0immunologically\u00a0phph\u00a0dimevin-1-linear\u00a0immunology-1.1-dene-1\u00a0cell\u00a0immunop\u00a0vinvin\u00a0decop\u00a0\u00a0\u00a0immun\u00a0\u00a0decvin\u00a0vin\u00a0\u00a0ph\u00a0\u00a0acvinvinvin-vin\u00a0dene\u00a0\u223c\u00a0\u00a01-ph\u00a0decone-dime\u00a0decor\u00a0\u00a0d\u00a0\u00a0house\u00a0immunone- or\u00a0decot-decor-decone/retro-immunology or\u00a0\u00a0cell-immunop\u2009decone or\u00a0~\u00a0\u00a0m\u00a0dec\u00a0\u00a05\u00a0\u00a0-\u00a0\u00a0is\u00a0\u00a0un\u00a0\u00a0c\u00a0\u00a0\u202fcell\u00a0\u00a0v\u00a0\u00a07\u00a0\u00a0\u2009\u00a0\u00a0\u00a0immun\u202fimmun\u00a0dec\u202f\u00a0\u00a0sp\u00a0\u00a0vin\u202fdec\u00a05\u202f\u00a0cell\u202f\u00a0dec\u2009\u00a0-\u2009\u00a0immun\u2009\u00a0dec-\u00a0dec5\u00a0\u202f-\u00a0ph\u2009\u00a0\u202f\u202f\u00a0\u202f\u00a0immun-immun\u00a0\u202fph\u00a0\u202fimmun\u202f\u00a0ph\u202f\u00a0\u2009-\u00a0\u2009\u2009\u00a0\u00a0\u00a0~\u2009\u00a0cell\u2009\u00a0\u2009immun\u00a0\u2009dec\u00a0\u202f\u2009\u00a0un\u202f\u00a0un\u2009\u00a0sp\u202f\u00a0vin\u2009\u00a0~\u202f\u00a0"}
{"slide_id": "TCGA-WY-A859-01Z-00-DX1.650758FF-1BE8-4A56-8A9A-319BA0363D8F", "reference": "The pathology report describes a brain tumor in a female patient. The tumor is identified as a gemistocytic type astrocytoma, WHO grade II, with some regions showing characteristics of a grade III astrocytoma but with a low MIB-1 index. The report includes gross descriptions of three parts of the tumor received for frozen section and permanent sections. The sections confirm the presence of a low-grade glioma in the brain tissue. Multiple soft white-red fragments of tissue with different dimensions are entirely submitted for analysis. Representative sections are also submitted for the specimen's soft pale tan-red nodules. All sections are fixed in 20% formalin overnight for further analysis. The report does not provide any information regarding the patient's treatment plan or sample size, shape, or weight.", "prediction": "-immunop-nanop-protein-gen\u00a0total\u00a0immunop\u00a0gen\u00a0in\u00a0total-protein\u00a0\u00a0\u00a0immun\u00a0\u00a0total\u2009\u00a0\u00a0gen-\u00a0\u00a0protein-immun\u00a0immunot\u00a0\u00a0prof\u00a0\u00a0un\u00a0\u00a0nanop\u00a0\u00a0hen\u00a0immunotoxin-protein\u2009\u2009\u00a0gen\u2009gen\u00a0\u00a0tot\u00a0\u00a0in\u2009gen\u2009\u00a0protein\u00a0immunoen\u00a0\u00a0terminal\u00a0\u00a0ret\u00a0immunologic\u00a0\u00a03\u00a0\u00a0d\u00a0genop-gen-protein total\u00a0\u00a0vinvin\u00a0\u00a0ph\u00a0\u00a0ep\u00a0gengen\u00a0protein\u2009\u00a0immun\u2009\u00a0hen\u2009\u00a0in-\u00a0immunotr\u00a0\u00a0cell\u00a0\u00a0pro\u00a0\u00a0\u2009\u00a0profgen\u00a0immun-\u00a0\u2009protein\u00a0hen-immun\u2009\u2009protein-hen\u00a0\u00a0v\u00a0\u00a0tumor\u00a0\u00a0-\u2009\u00a03-immun-protein immun\u00a0\u00a0drug\u00a0\u00a05\u00a0\u00a0human\u00a0\u00a0ne\u00a0\u00a0up\u00a0\u00a01\u00a0\u00a0h\u00a0\u00a0or\u00a0immungen\u00a0\u2009\u2009\u2009immun\u00a0protein terminal\u00a0immunology-\u00a0protein immun\u2009\u00a0terminal\u2009\u00a0\u2009gen-gen\u2009\u2009gengen-terminal-\u00a0gen immun\u00a0immun immun\u00a0gen cotreatment\u00a0\u00a0\u00a0\u00a0con\u00a0"}
{"slide_id": "TCGA-G4-6304-01Z-00-DX1.cf678a4f-5448-4d6a-a36f-cd1aec4d48a7", "reference": "The pathology report describes an en bloc resection specimen consisting of the terminal ileum, right colon, transverse colon, greater curvature of the stomach, mid-jejunum, and abdominal wall. The invasive poorly differentiated adenocarcinoma is present in the terminal ileum, right colon, transverse colon, omentum, mid-jejunum, greater curvature of the stomach, and abdominal wall. The invasive carcinoma is 4.5 x 4.5 cm while focal squamous differentiation is also present. The lymph nodes (25) are negative for cancer. The gastric mucosa has focal chronic gastritis while the margins are negative for carcinoma. The excision of the gastric suture line reveals no tumor. The tumor site is the transverse colon, which has an infiltrative and ulcerating configuration. The tumor size is 4.5 x 4.5 cm, and it is classified as adenocarcinoma with a histologic grade of G3. The margins are deemed negative for carcinoma while lymphovascular and perineural invasion are not noted. Other pathologic findings include abscess formation and dense adhesions. The extent of resection is R0, and the pathologic stage is pT4 NO Mx. Multiple lymph nodes that are grossly negative for tumor are seen, and a representative section of various tissues is submitted for examination.", "prediction": "-1-mermer-1 total-human-1\u00a0mer-mer-immunology-1.1-5-mer\u00a0immunopmer-5\u00a0\u00a0\u00a0house\u00a0\u00a01- or total\u00a0immunology\u00a0\u00a0-\u00a01\u00a0\u00a0mer\u00a0\u00a0unmer- or greater\u00a0immunologic greater\u00a0\u00a05- or\u00a01.mer- and greater\u00a0duro-gen-1 or greater urinary-immunologic or targeted-protein-10-immunologically targeted topped-immunotrogen-7-immunodepmer tororo-immunop-mer targeted\u00a0\u00a07\u00a0\u00a0to\u00a0\u00a0du-mer or\u00a0\u00a03\u00a0\u00a0sp\u00a0\u00a0other\u00a0un\u00a0\u00a0targeted-\u00a0\u00a0immun\u00a0\u00a02\u00a0\u00a0total\u00a0\u00a0cell\u00a0\u00a04\u00a0\u00a0ph\u00a0\u00a0\u202f\u00a0\u00a0end\u00a0\u00a0or\u00a0\u00a0protein\u00a0\u00a0otr\u00a0\u00a0we\u00a0\u00a0in\u00a0\u00a0trans\u00a0\u00a0(\u00a0\u00a0\u00a0immun-\u00a0immunotr\u00a0dumer-targeted\u00a0immunother\u00a0\u00a00-\u00a0spun\u00a01 to\u00a0immunologically\u00a0\u00a0gen\u00a0\u00a0one-\u00a0du\u00a0\u00a0 or\u00a0-1\u202f\u00a0mermer\u00a0"}
{"slide_id": "TCGA-DU-6396-01Z-00-DX1.0a818d89-d17b-45aa-85ce-d3a6631b7807", "reference": "The pathology report describes the results of five brain biopsies from one patient. Four biopsies show infiltrating malignant gliomas with features of anaplasia, including prominent nuclear pleomorphism, mitotic figures, and occasional individual cell necrosis. These tumors also have gemistocytic astrocytoma and anaplastic oligodendroglioma features. Only one biopsy shows atypical glial proliferation. The MIB-1 index is 2%, and there are no areas of necrosis or vascular endothelial proliferation observed. The neoplasms are classified as grade III/IV. Immunoperoxidase staining for GFAP demonstrates macro and mini gemistocytic phenotypes of tumor cells.", "prediction": " total-immunology-mermer-1-mer-human-human total\u00a0immunopmer-4-mer\u00a0\u00a0\u00a01-human\u00a0immun\u00a0\u00a0mer\u00a0immun-1\u00a0\u00a0human\u00a0\u00a0cell\u00a0\u00a0immunology\u00a0\u00a0ph\u00a0\u00a0un\u00a0\u00a0du\u00a0\u00a0-\u00a0\u00a07\u00a0\u00a0sp\u00a0\u00a0total\u00a0\u00a05\u00a0immunologic\u00a0du                                    \u00a0\u00a0d-mer to\u00a0human-10\u00a0immunotromer-immunot\u00a0immunombomb- or\u00a0duro-gen-1 to turro-immunop\u00a0\u00a0protein- and\u00a0\u00a0other\u00a0du-mer or\u00a0\u00a08\u00a0\u00a0to\u00a0\u00a010\u00a0\u00a0more\u00a0\u00a0pr\u00a0\u00a04\u00a0\u00a0we\u00a0\u00a0omb\u00a0\u00a02\u00a0\u00a0drug-\u00a0immunother\u00a0\u00a0race\u00a0\u00a03\u00a0\u00a0otr\u00a0\u00a0ology-\u00a01\u00a0other-immun\u00a0otherologic\u00a0\u00a0one\u00a0\u00a0trans\u00a0\u00a0poly\u00a0\u00a0\u2009\u00a0\u00a0tum\u00a0\u00a0or\u00a0\u00a0(\u00a0\u00a00\u00a0\u00a0\u202f\u00a0\u00a0 \u00a0\u00a0genome\u00a0\u00a0targeted\u00a0\u00a0\u00a0\u00a0end\u00a0\u00a0Western\u00a0\u00a0ologic\u00a0immunotr\u00a0dumer-\u00a0cell-immun-\u00a0"}
{"slide_id": "TCGA-BG-A0VT-01Z-00-DX1.BF02CE43-4FEC-4ED6-960B-5B1AEC51AA24", "reference": "The patient underwent laparoscopic abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, bilateral pelvic and para-aortic lymph node dissection, and pelvic biopsies due to endometrial cancer. Molecular testing identified loss of heterozygosity in both endometrial and ovarian tumors. The uterine tumor was moderately differentiated endometroid adenocarcinoma with involvement of anterior and posterior endomyometrium, endocervical glands, and cervical stroma. Complex endometrial hyperplasia with atypia and adenomyosis were also present. Lymph nodes were negative for cancer. The ovarian tumor was moderately differentiated endometroid carcinoma with marked cytoplasmic atypia and a ruptured tumor capsule. No positive lymph nodes were found. The ovarian tumor was staged as pT2c and FIGO stage IIC.", "prediction": "\u00a0phphphop\u00a0nan\u00a0\u00a0\u00a0cell\u00a0\u00a0immun\u00a0\u00a0nanop\u00a0\u00a0protein\u00a0\u00a0more\u00a0\u00a0ph\u00a0\u00a0dec\u00a0\u00a0\u2009\u00a0\u00a0\u00a0cell-\u00a0\u00a0v\u00a0\u00a0total\u00a0\u00a0sp\u00a0\u00a0m\u00a0\u00a0ret\u00a0immunop\u00a0\u2009\u2009\u00a0dec\u2009\u00a0ph\u2009\u00a0cell\u2009\u00a0immun\u2009\u00a0more-\u00a0decop\u00a0dec                        \u00a0\u00a03\u00a0\u00a0nm\u00a0\u00a0pro\u00a0\u00a0s\u00a0\u00a0d\u00a0\u00a0in\u00a0\u00a0ne\u00a0\u00a0terminal\u00a0\u00a05\u00a0\u00a0tum\u00a0\u00a0pr\u00a0\u00a0r\u00a0\u00a0tet\u00a0\u00a0-\u00a0cell            \u00a0dec-cell\u00a0nan\u2009\u00a0\u2009cell\u00a0dec\u202f\u00a0\u00a0is\u00a0\u00a07\u00a0\u00a0drug\u00a0\u00a010\u00a0\u00a0we\u00a0\u00a0Western\u00a0\u00a0\u202f\u00a0cell\u202f\u00a0\u2009ph\u00a0\u2009dec\u00a0\u2009nan\u00a0\u2009protein\u00a0\u2009immun\u00a0\u2009-\u00a0\u2009\u2009\u00a0protein\u2009\u00a0\u00a0\u00a0Trans\u00a0\u00a0vin\u00a0\u00a0(\u00a0\u00a0\u200a\u00a0\u00a0or\u00a0\u00a0at\u00a0\u00a0house\u00a0\u00a0 Cancer\u00a0\u00a0&\u00a0\u00a0sequ\u00a0\u00a0            \u00a0cellcell\u00a0\u2009more\u00a0\u2009\u202f\u00a0immun-\u00a0immun\u202f\u00a0phcell\u00a0\u2009\u2009\u2009\u00a0immuncell\u00a0"}
{"slide_id": "TCGA-P3-A6SX-01Z-00-DX1.AB3C5814-D645-4ED3-B81D-683E9FA0BBA5", "reference": "The pathology report describes the excisions made during the left tonsil tumor resection procedure in a  patient. The specimen includes several tissue samples labeled and submitted in formalin. The report indicates the presence of lymph nodes and detailed information on the size and characteristics of squamous cell carcinoma, including foci of angiolymphatic and perineural space invasion, invasion of underlying skeletal muscle, very focal invasion of minor salivary gland tissue, and no apparent gross bony invasion. According to the report, there is no evidence of metastatic carcinoma in the soft tissue, designated left level III excision. Lymph nodes designated as left neck dissection (level II and III) show metastatic carcinoma in only one of the 26 lymph nodes and no evidence of extracapsular soft tissue extension. Furthermore, there is no evidence of metastatic carcinoma in 4 lymph nodes designated left, level IA excision or level V, excision, which contains 5 lymph nodes. The overall diagnosis is invasive squamous cell carcinoma with a size of 3.5 cm and moderately differentiated. The report suggests the inked surgical margins are free of carcinoma. However, there are foci that approximate the margins, which are interpreted as tissue tear-distortion with ink run-off, and not free margins. Pending decalcification, assessment of bony invasion and bony margins will lead to the reporting of the results as an addendum.", "prediction": " total\u00a0in\u00a0human-human-1- and total-human targeted-immunology-protein-1\u00a0cell-1 to human- and human-human\u00a0phop\u00a0in total targeted\u00a0immunop\u00a0\u00a0\u00a0cell\u00a0\u00a0pr\u00a0\u00a01- or greater\u00a0\u00a0ph\u00a0\u00a0immunologic\u00a0\u00a0-\u00a0\u00a0human\u00a0\u00a0end\u00a0\u00a05\u00a0to greater\u00a0total\u00a0up\u00a0to\u00a0immunology to\u00a0men\u00a0in-1 or total cancer- and\u00a0gen-1 and targeted to total and\u00a0\u00a0genop\u00a0phin- or\u00a0\u00a07\u00a0\u00a0targeted\u00a0\u00a03\u00a0\u00a0other\u00a0\u00a0at\u00a0\u00a0protein\u00a0\u00a04\u00a0\u00a0sp\u00a0\u00a0op\u00a0other-in\u00a0\u00a0drug-\u00a0pr \u00a0\u00a0we\u00a0\u00a0\u2009\u00a0\u00a0\u202f\u00a0\u00a0du\u00a0\u00a08\u00a0\u00a0ne\u00a0\u00a0(\u00a0\u00a010\u00a0\u00a0mer\u00a0\u00a0tumor\u00a0pr-\u00a05-cell-\u00a01\u00a0\u00a0trans\u00a0\u00a0is\u00a0\u00a0ep\u00a0\u00a0or\u00a0\u00a0am\u00a0\u00a0ology-\u00a0immun\u00a0\u00a0            \u00a0\u00a0 \u00a0prpr\u00a05 \u00a0immunotr\u00a0\u00a0 and\u00a0immun-\u00a0phology-immun\u00a0"}
{"slide_id": "TCGA-S9-A6UA-01Z-00-DX1.99AB8786-858B-46A0-94BA-C5AA1CD5351B", "reference": "Histology and morphology are consistent with anaplastic astrocytoma WHO grade III. Diagnosis is anaplastic astrocytoma WHO grade III.", "prediction": "\u00a0up- or or\u00a0more- or\u00a0nequor-1-pr\u00a0or\u00a0\u00a0compar\u00a0\u00a0\u00a0sp\u00a0\u00a0or-\u00a0\u00a0house\u00a0\u00a0pr\u00a0\u00a0more\u00a0\u00a0du- or greater\u00a0\u00a0qu\u00a0\u00a0-\u00a0neur\u00a0\u00a0sequ\u00a0\u00a0+\u00a0\u00a0ne\u00a0\u00a0ct\u00a0\u00a0 or\u00a0\u00a05\u00a0\u00a0terminal\u00a0\u00a0c-\u00a0prur\u00a0prpr\u00a0other\u00a0\u00a0in\u00a0\u00a04- or viral\u00a0\u00a0other-\u00a0compar- or\u2009-\u00a0sp-\u00a0or\u2009\u00a0\u00a01- or vector\u00a0\u00a0clinically or\u00a0pr-\u00a0duct\u00a0neovascular\u00a0\u00a07\u00a0\u00a0targeted\u00a0\u00a03\u00a0\u00a0duction\u00a0\u00a0mer\u00a0\u00a0we\u00a0\u00a0ur\u00a0spur\u00a0nector\u00a0pror\u00a0spor\u00a0nepr\u00a0neor\u00a0-\u2009\u00a0spotr\u00a0\u00a06\u00a0\u00a0\u2011\u00a0\u00a08\u00a0\u00a0drug-\u00a04\u00a0\u00a0pro- or-prpr-or\u00a0du\u00a0pr\u2009or\u00a0ctor-or-pr-4\u00a0prneur-4-nequ\u00a0pr\u202for\u00a05-\u00a0ctpr\u00a04ct\u00a0orct\u00a0-prurct\u00a0pr4-\u00a0mer-\u00a0"}
{"slide_id": "TCGA-QC-A6FX-01Z-00-DX1.361C75FD-85B7-4E61-B615-37CB44AF5187", "reference": "The report describes a radical resection of a pleomorphic undifferentiated sarcoma located on the left back. The tumor involves the deep, superior, and inferior resection margins and has a size of 5.0 cm. The mitotic rate is 12/10 high-power fields (HPF), and there is necrosis present. Two additional margins were excised, and no tumor is identified in either. The specimen is inked for orientation and representative sections are submitted for analysis. There are no other lesions identified. Microscopic examination was performed.", "prediction": "\u00a0immunopnanopnannanop\u00a0protein\u00a0we\u00a0nan\u00a0protein\u2009protein\u00a0\u00a0\u00a0cell\u00a0\u00a0more\u00a0nanop\u2009protein\u2009\u00a0\u00a0dec\u00a0\u00a0\u2009\u00a0protein-protein\u00a0\u2009\u2009\u00a0cell\u2009\u00a0dec\u2009nan\u00a0\u00a0protein\u202f\u00a0\u00a0\u00a0moremore\u00a0more\u2009dec\u00a0decaperob\u00a0decmore\u00a0decat\u00a0\u00a0nanat\u00a0protein\u2005protein\u00a0decop\u00a0\u00a0v\u00a0decrob\u00a0\u00a0at\u00a0morenan\u00a0more protein\u00a0\u00a0ret\u00a0protein kinase\u00a0\u00a03\u00a0\u00a0health\u00a0decret\u00a0\u00a010\u00a0\u00a0we\u2009\u00a0nannan\u00a0dec\u202fprotein\u00a0morevin\u00a0\u00a0Trans\u00a0\u00a07\u00a0\u00a0T\u00a0\u00a0pro\u00a0\u00a0drug\u00a0\u00a0ph\u00a0\u00a0immun\u00a0\u00a0activity\u00a0\u00a0qu\u00a0\u00a04\u00a0\u00a0vin\u00a0dec\u2005\u00a0\u00a0\u202f\u00a0decdec\u00a0\u2009protein\u202f\u2009\u00a0\u00a0\u00a0\u00c5\u00a0\u00a05\u00a0\u00a0than\u00a0\u00a0rob\u00a0\u2009dec\u2009\u00a0\u2009cell\u00a0\u2009we\u00a0\u00a0 Cancer\u00a0\u00a08\u00a0\u2009more\u00a0\u00a0(\u00a0\u00a0Here\u00a0\u00a0Ph\u00a0\u00a0\u2122\u00a0\u00a0sequ\u00a0\u00a0Ther\u00a0\u00a0&\u00a0\u00a0\u2005\u00a0\u2009\u202f\u00a0\u2009\u2009\u00a0Trans\u2009\u2009\u2009protein\u2005\u00a0"}
{"slide_id": "TCGA-60-2698-01Z-00-DX1.738ae69e-5170-46d6-b691-9f761f9a794b", "reference": "The pathology report includes five specimens: a portion of the 6th right rib, a biopsy of the middle lobe peribronchial lymph node, a right lower lobe, an excisional biopsy of lymph node #8, and an excisional biopsy of lymph node #4. Frozen section diagnosis revealed that FS2 was negative for metastatic disease, while FS3A and FS3B indicated a poorly differentiated non-small-cell carcinoma from the right lower lobe. The gross description for specimen 3 revealed a well-circumscribed solid tumor mass occupying a subhilar position within the central portion of the lobe. The specimens were submitted for diagnosis, and the report shows anthracosis and metastatic squamous cell carcinoma in lymph node #8. There was no evidence of tumor in lymph node #4. The report indicates that there is a transition from benign to neoplastic squamous epithelium and notable invasion seen in specimen #3I. The remainder of lung parenchyma shows congestion with no evidence of pneumonic process.", "prediction": "1-mermer-1-human total-1\u00a0mer-5-mer-7-1.1- or greater-gen-1 or greater\u00a01- and greater\u00a0house-1 to greater\u00a0immunology-4-5\u00a0\u00a0\u00a0house\u00a0\u00a01\u00a0\u00a0immunologic-1 and greater greater\u00a0d-1 greater greater than greater\u00a0duro-gen1-4 to total urinary-genotro-d-4.7-7\u00a0immunodeprogen-immunotromer-9-monotroro-immunopmer-3-mer toro- or targeted-immunologic or total\u00a0\u00a0spun- or\u00a0\u00a0un\u00a0\u00a0-\u00a0\u00a05\u00a0sp\u00a0\u00a03\u00a0\u00a0end\u00a0\u00a07\u00a0\u00a0targeted-un\u00a05-immunology\u00a0\u00a0mer\u00a0\u00a0other\u00a0\u00a04-mer\u00a0sp-\u00a03-immun\u00a0\u00a02-\u00a0spotr\u00a0\u00a0du\u00a0\u00a0ph\u00a0\u00a0\u202f\u00a0\u00a0trans-1\u202f1-\u00a0immun\u00a01 targeted\u00a0\u00a0\u00a0\u00a0we\u00a0\u00a00-\u00a01.\u00a0\u00a0cell\u00a0\u00a0total\u00a0immunop\u00a0\u00a0or\u00a0\u00a0d"}
{"slide_id": "TCGA-EB-A5SE-01Z-00-DX1.2E10E7EF-B902-479F-ACBF-E852836FF7B9", "reference": "Specimen type: Excision of tumor. Tumor site: Skin, trunk. Tumor size: 2.8x2x0.4cm. Histologic type: Nodular melanoma. Additional findings: Tumor is multcentric, 4th level of invasion in bigger nodule, 2 level of. invasion in smaller nodule. Comments: Breslow thickness 4.0mm.", "prediction": "1- and total-immunologic-1-protein-total-1\u00a0protein-1 total\u00a0in\u00a0total\u00a0\u00a0\u00a0immunologic\u00a0\u00a01\u00a0\u00a0human\u00a0immun\u00a0\u00a0protein\u00a0\u00a0targeted\u00a0\u00a0total-human\u00a0\u00a0ur\u00a0\u00a05\u00a0\u00a0pr\u00a0\u00a0other\u00a0\u00a0pre-\u00a0\u00a0du\u00a0\u00a0drug\u00a0\u00a0-\u00a01-drug-immunotherapeutic\u00a0\u00a0more\u00a0\u00a0~\u00a0\u00a03\u00a0\u00a0in total targeted- and\u00a0immunore-total\u00a0more-total and targeted\u00a0invere\u00a0\u00a0compar\u00a0\u00a04\u00a0\u00a0to\u00a0\u00a0(\u00a0\u00a07\u00a0\u00a0gen\u00a0\u00a0clinically\u00a0\u00a0ph\u00a0\u00a0\u2009\u00a0\u00a0pent\u00a0\u00a0less\u00a0\u00a06\u00a0\u00a0trans\u00a0\u00a0pro\u00a0\u00a0we\u00a0\u00a0\u00a0\u00a0terminal\u00a0\u00a0pe\u00a0\u00a0tot\u00a0\u00a0genome\u00a0\u00a02\u00a0\u00a00\u00a0\u00a0house\u00a0\u00a0sp\u00a0\u00a0vin\u00a0\u00a0pathologic\u00a0\u00a0mer\u00a0\u00a0un\u00a0\u00a0con\u00a0\u00a0ie\u00a0\u00a0inter\u00a0\u00a0treatment\u00a0\u00a0up\u00a0\u00a0 and\u00a0\u00a0c\u00a0\u00a0ape\u00a0\u00a0port\u00a0\u00a0ep\u00a0\u00a0otal\u00a0\u00a0cell\u00a0\u00a0pos\u00a0\u00a0itional\u00a0\u00a0phase\u00a0\u00a0+\u00a0\u00a08\u00a0"}
{"slide_id": "TCGA-VS-A8QF-01Z-00-DX1.D8DB41E0-8C0F-4394-A2A2-8721BE35644B", "reference": "Cervical biopsy reveals histological grade 2 invasive squamous cell carcinoma.", "prediction": " total\u00a0immunologic and human total urinary total-human total human-human-human\u00a0human\u00a0\u00a0\u00a0immunology-\u00a0\u00a01\u00a0\u00a0total\u00a0\u00a0human-immun\u00a0\u00a0mer\u00a0immun\u00a0human human\u00a0\u00a0-\u00a0human \u00a0\u00a0protein\u00a0\u00a0other\u00a0\u00a0in\u00a0\u00a0cell\u00a0\u00a0pr\u00a0\u00a0less\u00a0\u00a0ph\u00a0\u00a0clinically\u00a0\u00a0vet\u00a0immunologically total complete complete complete human human-immunologic total fully total surgical total disease-1-mer\u00a0\u00a0du\u00a0immun immun\u00a0\u00a0drug\u00a0\u00a0            \u00a0\u00a05\u00a0\u00a0more\u00a0\u00a0 human\u00a0immunotr\u00a0\u00a0pathologic\u00a0\u00a0\u00a0\u00a0\u2009\u00a0\u00a0sp\u00a0\u00a0\u202f\u00a0\u00a0 clinically\u00a0immun clinically\u00a0\u00a0(\u00a0\u00a07\u00a0\u00a0terminal\u00a0\u00a0\u200a\u00a0\u00a0tum\u00a0\u00a0 immun\u00a0immunother\u00a0immun-\u00a0immun disease-\u00a0other-\u00a0protein-\u00a0\u00a0immunimmunologic\u00a0\u00a0compar\u00a0\u00a03\u00a0\u00a0we\u00a0\u00a0trans\u00a0\u00a0genome\u00a0\u00a0wild\u00a0\u00a0pos\u00a0\u00a0gen\u00a0\u00a0ologic\u00a0immun \u00a0immunovascular\u00a0\u00a0 and\u00a0\u00a0oper\u00a0\u00a0meric\u00a0\u00a0targeted\u00a0\u00a04\u00a0\u00a0fer\u00a0\u00a0otr\u00a0immun biologic\u00a0\u00a0 \u00a0"}
{"slide_id": "TCGA-KK-A6E4-01Z-00-DX1.8A9FDF9E-02B8-403B-BF39-13BBB1357CFF", "reference": "The pathology report includes findings for the right and left pelvic lymph nodes and the prostate and seminal vesicles. The right and left pelvic lymph nodes each have two lymph nodes, and no tumors are present. The prostate and seminal vesicles have been diagnosed with prostatic adenocarcinoma, Gleason score 7 (3+4), and high-grade prostatic intraepithelial neoplasia (PIN). The tumor focus measures 2.5 x 1.5 cm in the largest cross-sectional dimension and is confined to the prostate, with margins of resection free of tumor. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. The report includes gross descriptions and section codes of the lymph nodes and prostate and seminal vesicles, and SNOMED codes are also listed.", "prediction": " total-immunology-human-human total\u00a0human-1-mer-human\u00a0immunop\u00a0\u00a0\u00a0human\u00a0human \u00a0\u00a0immunology\u00a0\u00a0total\u00a0\u00a01\u00a0\u00a0in\u00a0\u00a0protein\u00a0\u00a0rat\u00a0\u00a0un\u00a0\u00a0ph\u00a0\u00a0mer\u00a0\u00a0-\u00a0\u00a05\u00a0\u00a0ep\u00a0immunologic\u00a0\u00a0gen\u00a0\u00a0targeted\u00a0\u00a07\u00a0\u00a0drug-1 total human-human urinary targeted\u00a0immunologically to human-immunologic and targeted-immunopmer- and\u00a0total-gen\u00a01-drug- and human-1\u00a0mer-immun\u00a0\u00a03\u00a0\u00a0to\u00a0\u00a0cell\u00a0\u00a0pr\u00a0\u00a0other\u00a0\u00a0pre\u00a0\u00a0op\u00a0protein-\u00a0immun\u00a0immunotr\u00a0\u00a0\u2009\u00a0\u00a0we\u00a0\u00a0du\u00a0\u00a0(\u00a0\u00a0more\u00a0\u00a0end\u00a0\u00a0Western\u00a0\u00a04\u00a0\u00a0sp\u00a0\u00a0clinically\u00a0\u00a0prof\u00a0\u00a0\u202f\u00a0\u00a0trans\u00a0\u00a0\u00a0\u00a0at\u00a0\u00a0clinical\u00a0\u00a0terminal\u00a0\u00a0up\u00a0\u00a0tum\u00a0\u00a0or\u00a0\u00a0d\u00a0\u00a0wild\u00a0immun-\u00a0protein \u00a0immunother\u00a0protein\u2009\u00a0immunimmun\u00a0proteinology-\u00a0Western-immun-drug\u00a0\u00a0+\u00a0\u00a02\u00a0"}
{"slide_id": "TCGA-EJ-5527-01Z-00-DX1.238fcb19-9655-463e-ab50-b48b71e6970e", "reference": "The report describes a radical prostatectomy and bilateral pelvic lymph node dissection performed on a patient with a PSA value of 7.7 ng/ml and a history of prostatic adenocarcinoma. The final diagnosis includes adenocarcinoma involving both lobes of the prostate with a greatest histologic nodular diameter of 2.1 cm and extraprostatic extension present in the right posterior apex and posterior mid prostate. Extensive perineural invasion is identified, but no angiolymphatic invasion is present. All examined surgical resection margins are free of neoplasia, while the bilateral seminal vesicles and distal vasa deferentia are benign. The histologic grade is G3-4, and tertiary Gleason pattern 5 carcinoma component is present. Multifocal high-grade prostatic intraepithelial neoplasia is identified, with a TNM pathologic stage of pT3a NO MX. No evidence of neoplasia is found in lymph node excisions.", "prediction": "\u00a0phphphop\u00a0nanop-nanopnanop\u00a0immunology-protein-protein\u00a0nanotop\u00a0decop\u00a0ret\u00a0immunop\u00a0protein\u00a0cell\u00a0immun\u00a0nan\u00a0\u00a0\u00a0cell-immun\u00a0\u00a0more\u00a0dec\u00a0\u00a0ph\u00a0dec                                    \u00a0\u00a0immunoenvinvinvin\u00a0ph\u2009ph\u00a0phop\u2009nanopop\u00a0v\u00a0v-protein total\u00a0retret-immunop-decop-v\u00a0protein-v-cell-decot-protein,\u00a0\u00a0v\u2009decop\u2009dec\u00a0decis-dec\u00a0cellop-protein\u2009nan\u00a0dec-5\u00a0cell\u2009\u00a0\u00a0decot\u00a0\u00a05\u00a0\u00a0nan\u2009\u00a0immun-\u00a0\u00a0\u00a0\u00a0is\u00a0\u00a0protein\u2009\u00a0\u2009cell\u00a0\u00a03\u00a0\u00a0d\u00a0\u00a0s\u00a0\u00a0total\u00a0\u00a0vin\u00a0\u00a0\u2009\u00a0cell\u202f\u00a0\u00a07\u00a0\u00a0nm\u00a0\u00a0pro\u00a0\u00a0sp\u00a0\u00a0-\u00a0immunotr\u00a0\u00a0(\u00a0\u00a0drug\u00a0\u00a0Western\u00a0immun\u2009\u2009\u00a0protein\u202f\u00a0immun\u202f\u00a0\u2009\u2009\u2009protein\u00a0\u00a0house\u00a0\u00a0we\u00a0\u00a0\u202f\u00a0\u00a0immunimmun\u00a0\u2009immun\u00a0immuncell\u00a0\u2009\u2009\u2009\u00a0"}
{"slide_id": "TCGA-GC-A3YS-01Z-00-DX1.97B4664A-9D8B-460D-B4A4-89855D3DB0C2", "reference": "The pathology report includes information regarding various specimens collected during surgery, including biopsies of both ureters (which were negative for malignancy) and the bladder. The bladder specimen showed the presence of a urothelial carcinoma with focal squamous differentiation, as well as the presence of high-grade urothelial dysplasia/flat carcinoma in situ. The report also indicates lymphovascular space invasion and metastatic urothelial carcinoma found in a lymph node. The prostate gland specimen showed the presence of adenocarcinoma with a Gleason score of 6/10 and involvement of the prostatic apex margin but no lymph node involvement. The report confirms the diagnosis of the identified malignancies and provides relevant information for clinical evaluation and treatment planning.", "prediction": "\u00a0protein\u00a0immunop\u00a0nanopnanop-protein\u00a0protein\u2009nanop\u00a0immunology-protein\u2009protein\u00a0more\u00a0nan\u00a0immun\u00a0cell\u00a0dec\u00a0dec\u2009nan\u00a0protein-immun\u00a0\u00a0\u00a0immun\u2009protein\u2009\u00a0\u00a0cell-immunop\u2009dec\u00a0phph\u00a0\u00a0ret\u00a0immunoen\u00a0ret\u2009immunop-nanop\u2009protein-protein-dec\u00a0nanotop\u00a0retret\u00a0decop\u2009nanotis-protein total\u00a0protein tot\u00a0dec-dec\u2009dec\u2009protein\u202fdec\u00a0v\u00a0dec\u202fprotein\u00a0\u00a0v\u2009decop\u00a0\u00a0\u00a0cell\u2009nan\u2009\u00a0protein\u202f\u00a0\u00a0\u2009\u00a0cell\u202fimmun\u00a0nan\u2009\u2009\u00a0immun\u202fprotein\u2009\u2009\u2009\u2009\u00a0\u00a0\u00a0pro\u00a0\u00a0ph\u00a0immun-protein\u202f\u2009\u00a0\u2009cell\u00a0\u00a0vin\u00a0\u00a0we\u00a0\u00a0\u202f\u00a0immuncell\u00a0\u2009\u2009immun\u00a0\u2009immun\u2009\u00a0decvin\u00a0\u2009vin\u2009\u00a0ph\u2009\u00a0vin\u2009\u2009cell\u2009\u00a0pro\u2009\u00a0\u202f\u2009\u2009-\u00a0\u00a0protein Cancer\u00a0\u00a0(\u00a0\u00a0drug\u00a0\u00a0more\u2009\u00a0we\u2009\u00a0-\u2009\u00a0drug\u2009\u2009vin\u00a0protein,\u00a0\u00a0house\u00a0\u00a0terminal\u00a0\u00a0"}
{"slide_id": "TCGA-AJ-A23N-01Z-00-DX1.42F1DEED-AF28-4B78-B41C-F560F932F8F7", "reference": "The patient is a female with metastatic high-grade adenocarcinoma. The omentum and uterus are extensively infiltrated by the tumor. Histologic typing and grading reveal a serous carcinoma of endometrial origin. The tumor focally extends 0.3 cm into a 1.1 cm thick myometrium. Lymphovascular space invasion is not definitively identified, and surgical margin status is not definitive. The lymph node status indicates no lymph nodes were removed. The specimen received includes a portion of the omentum, omentum, and uterus with the right tube and ovary. The gross description indicates two gray-white tumor nodules ranging from 2.0 to 6.0 cm in the omentum. The uterus is 5.6 cm in length, and the right ovary measures 3.0 x 1.5 x 1.3 cm. The specimen is submitted for permanent sections. The frozen section diagnosis confirms metastatic adenocarcinoma. Immunohistochemical stains for WT-1 and P53 show positive staining for P53 with no to only focal nuclear staining for WT1. The diagnosis is pT3a NX (FIGO IIIA).", "prediction": "\u00a0nanop\u00a0phphphop\u00a0nannanop-protein\u00a0\u00a0nan\u00a0\u00a0\u00a0cell\u00a0\u00a0immun\u00a0\u00a0more\u00a0\u00a0ph\u00a0\u00a0dec\u00a0\u00a0\u2009\u00a0\u00a0protein\u00a0nan\u2009\u00a0cell-\u00a0\u00a0v\u00a0decop\u00a0\u00a0rat\u00a0\u00a03\u00a0\u00a0nm\u00a0\u00a0at\u00a0\u00a0\u00a0cellop\u00a0dec            \u00a0\u00a0ret\u00a0nanoform\u00a0\u00a0rob\u00a0\u00a0is\u00a0\u00a0pro\u00a0protein\u2009\u00a0ph\u2009\u00a0dec\u2009\u00a0protein-protein\u2009nanopop\u00a0cell\u2009dec\u00a0dec-dec\u00a0phop\u2009\u00a0nanotr\u00a0\u00a05\u00a0\u00a0terminal\u00a0\u00a07\u00a0\u00a0T\u00a0\u00a0pr\u00a0\u00a010\u00a0\u00a0tum\u00a0\u00a0in\u00a0\u00a0Trans\u00a0\u00a0we\u00a0\u00a0d\u00a0\u00a0            \u00a0cellcell\u00a0cell\u202f\u00a0\u00a0\u200a\u00a0\u00a0Western\u00a0\u00a0Di\u00a0\u00a0translational\u00a0\u00a0\u00c5\u00a0\u00a0l\u00a0\u00a0total\u00a0\u00a0drug\u00a0\u00a0or\u00a0\u00a0prof\u00a0\u00a0\u202f\u00a0cell            \u00a0phcell\u00a0\u2009\u2009\u00a0immun\u2009\u00a0\u2009cell\u00a0immunop\u00a0\u2009protein\u00a0\u2009nan\u00a0\u2009ph\u00a0\u2009\u202f\u00a0\u2009\u2009\u00a0\u00a0\u00a0(\u00a0\u00a0R\u00a0\u00a0 protein\u00a0\u00a0Here\u00a0\u00a0\u2005\u00a0\u00a0-\u2009\u00a0more\u2009"}
{"slide_id": "TCGA-3A-A9IC-01Z-00-DX1.C41BADB4-1DC2-41EC-8572-643C9421583F", "reference": "Final diagnosis: Invasive pancreatic ductal adenocarcinoma, moderately differentiated in the bile duct, pancreas, and duodenum (Whipple procedure). Additional pancreatic margin excision showed low-grade pancreatic intraepithelial neoplasia but no evidence of carcinoma or high-grade dysplasia. No distant metastasis detected. The tumor invades adjacent structures/organs (duodenum) and regional lymph nodes (pN1b). Margins are free of tumor with 1 mm distance of invasive carcinoma from the closest margin (retroperitoneal margin) and no venous invasion (V) but with both lymphatic invasion (L) and perineural invasion. Grossly, the specimen consists of resected portions of the pancreatic head and attached duodenum with a palpable pancreatic mass. The pancreatic duct is totally occluded by the presence of the tumor, which abuts the retroperitoneal surface/uncinate process, involves the common bile duct and the duodenal wall, and grossly involves the ampulla of Vater. Two moderate-sized lymph nodes with no grossly uninvolved pancreatic tissue are isolated. A representative section of the tumor is submitted to the Tissue Procurement Laboratory.", "prediction": "1- and total-protein-human-immunop\u00a0gen\u00a0total-gen\u00a0protein-1-protein total\u00a0total\u00a0in\u00a0human-human\u00a0immunology-1\u00a0protein\u00a0immunop-protein\u00a0targeted\u00a0\u00a0\u00a0un\u00a0gen-total\u00a0\u00a0immunologic\u00a0\u00a01\u00a0more\u00a0\u00a0total greater\u00a0\u00a0protein immunop greater\u00a0in greater greater\u00a0pre-gen1-drug-protein greater\u00a0total urinary-targeted\u00a0ingen-1 targeted\u00a0moregen-targeted-human targeted- and greater-total-pregen-gen-human immunop\u00a0\u00a0pregen\u00a0\u00a0targeted-\u00a0\u00a03\u00a0\u00a0human\u00a0\u00a05\u00a0\u00a0more-\u00a01-immun\u00a0\u00a0-\u00a0protein to\u00a0immun\u00a0protein\u2009\u00a0\u00a0we\u00a0immunotr\u00a0\u00a0(\u00a0\u00a0gen1\u00a0\u00a0terminal\u00a0\u00a0prof\u00a0\u00a0in-protein\u2009gen\u00a0genun\u00a0\u00a0vin\u00a0total\u2009protein\u00a0\u00a0drug\u00a0\u00a0du\u00a0protein more\u00a0\u00a0Western\u00a0immun-immunologic-immunology\u00a0\u00a0con\u00a0gengen-protein immun\u00a0\u00a0ep\u00a0proteingen\u00a0immungen\u00a0targetedtotal\u00a0protein,\u00a0\u00a0\u00a0immunologically\u00a0immunun\u00a0"}
{"slide_id": "TCGA-BP-5182-01Z-00-DX1.7c434449-e102-47ca-ab56-94f0621811f6", "reference": "A left renal mass and surrounding tissue were biopsied, and the left kidney was found to have a partial-nephrectomy. The tumor was identified as renal cell carcinoma - Conventional (clear cell) type, with a nuclear grade III/IV and a greatest diameter of 3.0 cm. No local invasion, renal vein invasion, or small vessel angiolymphatic invasion was identified, and the surgical margins were free of tumor. The non-neoplastic kidney showed mild arteriosclerotic changes, and no adrenal gland or lymph node involvement was identified. Additionally, benign samples of the left renal margin, left 11th rib, soft tissue left peri-nephric area, soft tissue over the tumor in the left kidney, and left hilar lymph node were biopsied. Intraoperative consultations confirmed the frozen section diagnosis of renal cortical tumor with a favorable prognosis for conventional renal cell carcinoma and negative margins. The permanent diagnosis remained the same for all biopsy samples.", "prediction": " total-immunologic and total\u00a0in\u00a0human\u00a0immunologic\u00a0\u00a0\u00a0total\u00a0total-human\u00a0human-human-immun\u00a0\u00a0immunop\u00a0\u00a01\u00a0\u00a0in-total\u00a0\u00a0protein\u00a0\u00a0tot\u00a0\u00a0up\u00a0\u00a0gen\u00a0\u00a0ur\u00a0\u00a0pre\u00a0\u00a0clinically\u00a0\u00a0targeted\u00a0\u00a0more\u00a0\u00a0human complete\u00a0\u00a0pr\u00a0\u00a0less\u00a0\u00a05\u00a0\u00a0drug\u00a0\u00a0du\u00a0\u00a0-\u00a0\u00a0            \u00a0\u00a0 greater\u00a0\u00a0pathologic\u00a0\u00a0vet\u00a0\u00a0(\u00a0\u00a0mer\u00a0\u00a0in\u00a0\u00a0to\u00a0\u00a0compar\u00a0\u00a07\u00a0\u00a0\u2011\u00a0\u00a03\u00a0\u00a0terminal\u00a0\u00a0\u2009\u00a0\u00a0pent\u00a0\u00a0 and\u00a0\u00a0vin\u00a0\u00a0 immun\u00a0\u00a0other\u00a0\u00a0\u202f\u00a0\u00a0trans\u00a0\u00a0un\u00a0\u00a0genome\u00a0\u00a04\u00a0\u00a0cell\u00a0\u00a0pro\u00a0\u00a0ie\u00a0\u00a0prof\u00a0\u00a0\u200a\u00a0\u00a0we\u00a0\u00a0end\u00a0\u00a0oper\u00a0\u00a0ph\u00a0\u00a0ep\u00a0immun\u00a0immunother\u00a0immunology\u00a0\u00a0meric\u00a0immunimmunologic-\u00a0immun-protein\u00a0immunotr\u00a0\u00a0pos\u00a0\u00a0itional\u00a0\u00a0+\u00a0\u00a00\u00a0\u00a0pe\u00a0\u00a0wild\u00a0\u00a0treatment\u00a0immunologically\u00a0\u00a0port\u00a0\u00a0directed\u00a0\u00a0con\u00a0immungen\u00a0"}
{"slide_id": "TCGA-BP-4972-01Z-00-DX1.912c5a3d-2c86-4c39-8c12-dcc0a18440e7", "reference": "Patient presented with a renal mass and underwent left partial nephrectomy. Pathology report reveals a renal cell carcinoma of conventional (clear cell) type with a Fuhrman Nuclear Grade of III/IV. Tumor size is 4.2 cm and there is local invasion beyond renal capsule but confined within Gerota's fascia. No renal vein invasion or small vessel angiolymphatic invasion is identified. Surgical margin is free of the tumor. Non-neoplastic kidney shows a benign cortical cyst. Adrenal gland and lymph nodes are not identified. The frozen section diagnosis shows renal cortical neoplasm with a negative margin, which is confirmed in the permanent diagnosis.", "prediction": "1-human-immunology-protein-1-total\u00a0in\u00a0human\u00a0human-human\u00a0immunop\u00a0gen\u00a0total\u00a0immunology\u00a0\u00a0\u00a0immunologic\u00a0\u00a01-protein\u00a0total-1\u00a0protein-immun\u00a0\u00a0phop\u00a0immun\u00a01\u00a0\u00a0targeted\u00a0\u00a0protein\u00a0\u00a0un\u00a0ph\u00a0targeted-immunologic-\u00a0\u00a0gen-1 total\u00a0\u00a0pre-gen1-drug-protein total-in\u00a0genur-targeted-total-immunop-gen\u00a0in-human targeted- and\u00a0\u00a0dugen-targeted\u00a01 to greater\u00a0\u00a0ur\u00a0immun-1\u2009\u00a0\u00a05\u00a0\u00a0-\u00a0immunot\u00a0\u00a0other\u00a0\u00a03\u00a0\u00a0we\u00a0\u00a0(\u00a0\u00a0in\u2009protein\u00a0immunother\u00a0immunotr\u00a0\u00a0pr\u00a0\u00a07\u00a0\u00a0drug\u00a0\u00a0total\u2009protein-\u00a01\u202f\u00a0\u00a00\u00a0\u00a0house\u00a0\u00a0vin\u00a0\u00a04\u00a0\u00a0trans\u00a0\u00a0clinically\u00a0\u00a0ep\u00a0genologic\u00a0protein targeted\u00a0(1-immunothergen\u00a0\u00a0\u00a0\u00a0Western\u00a0immunimmun\u00a0genology-immun-immunimmunologyology-\u00a0proteinology-targeted-immunotrgen\u00a0gen1\u00a0"}
{"slide_id": "TCGA-A3-3372-01Z-00-DX1.6a238433-934b-4a03-a35e-4728658eea84", "reference": "Filtered Pathology Report: \r\n\r\nFinal Diagnosis: Left kidney: Renal cell carcinoma, clear cell type. Tumor site: Lateral aspect of the lower pole extending into the central portion of the kidney. Tumor size: 6.9 x 5.5 X 5.3 cm. Nuclear grade: Fuhrman grade 2/4. Lymphovascular space invasion: No. Transcapsular invasion: Yes. Renal vein invasion: No. Vena caval invasion: Not resected. Adrenal gland: Benign adrenal gland tissue without evidence of metastatic disease. Surgical margin status: Soft tissue margins Negative. Ureteral margin: Negative. Vascular margins: Negative. Other: Chronic pyelonephritis. The test has been finalized at the Campus. #.", "prediction": " total-immunology-protein-human-human\u00a0immunop\u00a0un\u00a0phun\u00a0protein-1-protein\u00a0immunology\u00a0\u00a0immun\u00a0\u00a0\u00a0ph\u00a0un-1\u00a0phphun-immun\u00a0immunologic\u00a0\u00a01\u00a0\u00a0we\u00a0\u00a0human\u00a0\u00a0du\u00a0\u00a0protein\u00a0\u00a0house\u00a0\u00a0-\u00a0immunotro-immunologic-immunop-ph\u00a0immunologically targeted-immunologically-targeted-drug-protein total\u00a0protein to\u00a0gen\u00a0gen-protein and total cancer-immunot-protein or\u00a0human-phop\u00a0in\u00a0\u00a0cell\u00a0\u00a0un\u2009\u00a0\u00a07\u00a0\u00a0total\u00a0\u00a0other\u00a0\u00a0pr\u00a0\u00a05\u00a0\u00a0to\u00a0immunun\u00a0\u00a0drug-\u00a0\u00a0\u2009\u00a0immun-\u00a0un\u202f\u00a0\u00a0sp\u00a0\u00a0\u202fimmun\u00a0du-\u00a0ph-\u00a01-cell\u00a0immunotr\u00a0\u00a0Western\u00a0\u00a0poly\u00a0\u00a0targeted\u00a0\u00a0ologyology-\u00a0protein\u2009-\u00a0wewe\u00a0immunother\u00a0phology-un\u00a0immun\u2009\u00a0duology-1\u2009\u00a0we-immun-protein\u2009immun\u00a0proteinology-immun\u2009protein\u00a0du\u2009\u00a0ph\u2009\u00a0protein\u202f\u00a0weimmun\u00a0-1\u202f\u00a0"}
{"slide_id": "TCGA-BP-4769-01Z-00-DX1.c13d841b-b3f6-4d86-b1c1-94e850a8fa44", "reference": "A 3 cm exophytic left renal mass was diagnosed as conventional (clear cell) type renal cell carcinoma. Another papillary type renal cell carcinoma was also detected. The clear cell carcinoma had a nuclear grade of II/IV and was 2.2 cm in size, while the papillary tumor was type 1 and measured 1.1 cm. Local invasion was not identified, renal vein invasion was not detected and surgical margins were free of tumor. A few non-neoplastic minute papillary tubular adenomas were present. Adrenal gland and lymph nodes were not identified. The staging for renal cell carcinoma/oncocytoma was pT1 with a tumor size <= 7.0 cm in greatest dimension limited to the kidney. The left kidney was partially nephrectomized. Tumor number one was well-circumscribed and grossly located 0.2 cm from the resection margin, while tumor number two was friable, necrotic and located 0.3 cm from the resection margin. The renal capsule was not involved. Intraoperative consultation showed negative margins for both tumors, which was confirmed as permanent diagnosis.", "prediction": "-immunology-protein-immunop\u00a0protein-human-human\u00a0immunop-protein\u00a0immunology\u00a0rat\u00a0total\u00a0in\u00a0human\u00a0phop\u00a0un\u00a0phun\u00a0immun\u00a0protein\u00a0total-immun\u00a0\u00a0\u00a0ph\u00a0immunoprevin\u00a0\u00a0rat-\u00a0\u00a0immunologic\u00a0\u00a0un\u2009protein\u00a0\u00a0total\u2009immunop\u2009protein-protein total\u00a0immunologically-immunologic-drug-immunologically\u00a0in-genop\u00a0genop-in-human total-in\u00a0gen\u00a0protein targeted-immunopregen\u00a0\u00a0cell\u00a0immun-immunotr\u00a0\u00a0targeted-cell\u00a0phph\u00a0\u00a0in\u2009\u00a0\u00a0we\u00a0\u00a0drug-protein\u2009immun\u00a0immunot\u00a0\u00a01\u00a0\u00a0protein\u2009\u00a0immunother\u00a0\u00a0Western\u00a0\u00a0-\u00a0immunimmun\u00a0phin\u00a0\u00a0other\u00a0we-immun-drug\u00a0\u00a0human-immun\u2009protein\u2009total\u00a0\u00a03\u00a0immunotoxin\u00a0\u00a0pro\u00a0\u00a0gen-protein\u202fprotein\u00a0wewe\u00a0immun immun\u00a0\u00a0terminal\u00a0immun\u2009\u00a0proteinology-immunimmunologyology-\u00a0Western-immun immunop\u00a0\u00a0\u00a0immunun\u00a0\u00a0du\u00a0immunph\u00a0protein,\u00a0\u00a0ret\u00a0immunotr"}
{"slide_id": "TCGA-BP-5185-01Z-00-DX1.e965a765-7610-4299-8a21-b4e004f6892e", "reference": "Patient History: Right renal mass. \r\n\r\nSpecimens Submitted: \r\n1. SP: Kidney, right, partial nephrectomy.\r\n2. SP: Kidney, right, biopsy. \r\n\r\nDiagnosis: \r\n1. SP: Kidney, right, partial nephrectomy: Renal cell carcinoma - Conventional (clear cell) type with Fuhrman Nuclear Grade III/IV. Tumor size is 3.3 cm in greatest diameter, with no local or renal vein invasion and surgical margins free of tumor. Non-neoplastic kidney is unremarkable. \r\n2. SP: Kidney, right, biopsy: Mild Diabetic Nephropathy with focal segmental and global glomerulosclerosis, tubular atrophy, and mild interstitial fibrosis. No other specific glomerular lesions identified.\r\n\r\nIntraoperative consultation: Renal cortical neoplasm with the margin appearing free on one representative section. Permanent diagnosis: same.", "prediction": "\u00a0immunology-protein\u00a0immunop\u00a0protein\u00a0total\u00a0protein-immunop\u2009ph\u00a0ph\u00a0total-protein-ph\u00a0retin-immunology\u00a0\u00a0\u00a0immun\u00a0phop\u00a0ph\u2009total\u00a0\u00a0cell\u00a0immun-immun\u00a0\u00a0phph\u00a0\u00a0ret\u00a0immunologically\u00a0\u00a0un\u00a0ph-ph-immun-drug-protein total\u00a0ret-immunologically-drug\u00a0immunotop\u00a0in\u00a0protein targeted-protein\u2009protein\u00a0\u00a0drug-drug total-cell-immunoprene-protein and\u00a0\u00a0more\u00a0immunologic\u00a0cell-cell\u00a0\u00a0in\u2009protein-\u00a0\u00a0we\u00a0\u00a0protein\u2009\u00a0\u00a07\u00a0immunotr\u00a0\u00a0Western\u00a0\u00a0pro\u00a0\u00a0-\u00a0immun\u2009immun\u00a0drug\u00a0\u00a0total\u2009\u00a0protein\u202f\u00a0\u00a01\u00a0\u00a0pr\u00a0\u00a05\u00a0\u00a0terminal\u00a0\u00a0ne\u00a0immunotoxin\u00a0\u00a0\u00a0immunother\u00a0\u00a0nan\u00a0\u00a0other\u00a0phun\u00a0\u00a03\u00a0\u00a0gen\u00a0\u00a0targeted\u00a0\u00a0du\u00a0\u00a0\u2009\u00a0immunimmun\u00a0proteinology-\u00a0Western-immun\u2009drug\u00a0photr\u00a0protein kinase\u00a0\u00a0or\u00a0\u00a0dec\u00a0\u00a0otr\u00a0immunph\u00a0Western immun\u00a0\u00a0vin\u00a0\u00a0d\u00a0"}
{"slide_id": "TCGA-BP-4992-01Z-00-DX1.3f676d40-00de-4eb4-971d-6b93ed165cf5", "reference": "A total nephrectomy of the left kidney was performed due to a renal cell carcinoma - conventional (clear cell) type with focal sercomatoid features of nuclear grade IV/IV. The tumor measured 5.6 cm in diameter and showed no local invasion or renal vein invasion. The surgical margins were free of tumor, and non-neoplastic kidney tissue showed benign cortical cysts, papillary edenomas, and mild arteriosclerotic changes. The adrenal gland and lymph nodes were not identified. The perinephric fat showed benign fibroadipose tissue. Intraoperative consultation confirmed the diagnosis of renal cortical carcinoma, which was confirmed by permanent sections.", "prediction": "1-mermer-human-immunology-1-human total-immunologic-human\u00a0immunop\u00a01- and\u00a0human-1\u00a0total-1.1-protein-immunop-mer-total-5\u00a0immunologic\u00a0\u00a0\u00a0immunology\u00a0\u00a01\u00a0\u00a0human\u00a0phop\u00a0mer-1 targeted\u00a0\u00a0house\u00a0\u00a03-mer\u00a0immunotro-gen-protein targeted-human urinary-protein\u00a0\u00a0gen-targeted-immunologically targeted to human-immunodepmer-targeted total\u00a0dugen-1 and greater\u00a0duro-immunopremer-immun\u00a0\u00a05\u00a0total\u00a0\u00a0targeted-\u00a0\u00a0other\u00a0\u00a0protein-targeted\u00a03\u00a0\u00a0un\u00a0\u00a0-\u00a05-\u00a0immun\u00a0immunotr\u00a0\u00a0we\u00a0\u00a0du\u00a0protein\u00a0other-immun-1\u2009\u00a0\u00a0sp\u00a0\u00a0merologic-immunother\u00a0(1-\u00a01\u202f\u00a0\u00a0phologic-\u00a0targeted\u00a0(3-\u00a0mer\u00a0\u00a02\u00a0\u00a00\u00a0\u00a0(\u00a0\u00a0\u00a0immun-merologic\u00a0immunotherology-immunotrgen\u00a0\u00a04-immun1-immunmer-\u00a0duology-\u00a0(5\u00a0"}
{"slide_id": "TCGA-BP-5187-01Z-00-DX1.638c8e8b-090f-4312-89ad-92ccfc1eaa7b", "reference": "Clinical Diagnosis & History: Right renal mass. Specimens Submitted: 1. Kidney, right upper pole, partial nephrectomy. DIAGNOSIS: 1. Kidney, right upper pole, partial nephrectomy: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 3.5 cm. Local Invasion (for renal cortical types): Not identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Focal chronic inflammation and vascular sclerosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm In greatest dimension limited to the kidney. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh labeled \"Right upper pole partial nephrectomy\". It consists of a 50 g, 4.5 x 4.5 x 3.5 cm portion of renal parenchyma with attached fat measuring 7.1 x 3.8 x 2.2 cm. The resected margin of the specimen is inked black. The specimen is sectioned to reveal a 3.5 x 3.2 x 2.5 cm well-circumscribed hemorrhagic mass which is located 0.5 cm from the closest resected margin. The mass abuts the renal capsule but does not grossly involve it. The remainder of the renal parenchyma is brown-tan and grossly unremarkable. Representative sections are submitted. A sample of the tumor is given to TPS. Summary of sections: TM - tumor with margin. TC - tumor with renal capsule. RS - representative section of uninvolved kidney. TN - tumor with normal kidney. Summary of Sections: Part 1: Kidney, right upper pole, partial nephrectomy. Block. Sect. Site. PCs. 1. fsc. 1. rs. 1. 1. to. 1. 2. tm. 2.", "prediction": "immunologic and total-immunologic-protein-1-human-human total\u00a0in\u00a0human\u00a0human-1\u00a0prin\u00a0\u00a0\u00a0immunologic\u00a01\u00a0\u00a0total\u00a0immunology-human\u00a0immun\u00a0\u00a01-\u00a0\u00a0protein\u00a0\u00a0other\u00a0\u00a0pr\u00a0\u00a0gen\u00a0\u00a0du\u00a0\u00a0ph\u00a0\u00a0ur\u00a0\u00a0-\u00a0immunotherapeutic\u00a0\u00a0targeted\u00a0\u00a0human targeted-immunologically targeted\u00a0total-in\u00a0gen-total-protein total and\u00a0immunop\u00a0in-drug-immunology\u00a0\u00a0pre\u00a0\u00a0clinically\u00a0\u00a0~\u00a0\u00a05\u00a0\u00a0more\u00a0\u00a0(\u00a0\u00a0drug\u00a0\u00a07\u00a0\u00a03\u00a0\u00a0we\u00a0\u00a0\u2009\u00a0\u00a0\u00a0\u00a0compar\u00a0\u00a0pent\u00a0\u00a0            \u00a0\u00a0sp\u00a0\u00a04\u00a0immun-immun\u00a0immunotr\u00a0\u00a0pathologic\u00a0\u00a0\u202f\u00a0\u00a0genome\u00a0\u00a0positional\u00a0\u00a0end\u00a0\u00a0mer\u00a0\u00a00\u00a0\u00a0trans\u00a0\u00a0ie\u00a0\u00a0wild\u00a0immun(\u00a0immunimmun\u00a0protein-immunother\u00a0dupr\u00a0dugen\u00a0(1\u00a0protein \u00a0\u00a02\u00a0\u00a0ep\u00a0\u00a0 and\u00a0\u00a0cell\u00a0\u00a0vin\u00a0\u00a0ape\u00a0\u00a0+\u00a0\u00a08\u00a0\u00a0"}
{"slide_id": "TCGA-BQ-7058-01Z-00-DX1.b2419f7a-e4af-467d-a0ee-c00b7ac33bdc", "reference": "Clinical Diagnosis & History: Right renal mass s/p IR biopsy that demonstrated high grade, renal cell carcinoma.\r\nSpecimens Submitted: 1: MESENTARY, OVERLYING RIGHT RENAL TUMOR; BIOPSY. 2: GEROTA'S FASCIA, ANTERIOR; BIOPSY. 3: KIDNEY. LOWER POLE AND CAVAL LYMPH NODES, PARTIAL NEPHRECTOMY.\r\nDiagnosis: 1. MESENTARY, OVERLYING RIGHT RENAL TUMOR; BIOPSY: -Benign fibrofatty tissue. 2. GEROTA'S FASCIA, ANTERIOR; BIOPSY: -Benign fibrofatty tissue. 3. KIDNEY, LOWER POLE AND CAVAL LYMPH NODES, PARTIAL NEPHRECTOMY: Tumor Type: Renal coll carcinoma - Unclassified type. High grade. Tumor Size: Greatest diameter is 4.2 cm. Local Invasion (for renal cortical types): Involves renal sinus fat. Renal Vein Invasion: Not identified. Surgical Margins: Tumor present at renal parenchymal margin (for partial nephrectomy specimens only). Non-Neoplastic Kidney: Chronic nephritis, mild arteriolonephrosclerosis. Adrenal Gland: Not identified. Lymph Nodes: Number of metastatic nodes: 3. Number of nodes examined: 8. Staging for renal cell carcinoma: pT3 Tumor extends into major veins or invades the adrenal gland or perinephric tissue but not beyond Gerota's fascia. Comment: High grade tumor has features seen in both distal nephron (collecting duct) and \"type 2\" papillary renal carcinoma.\r\nSpecial Studies: Special Stain. Comment. PAS. 34BE 12. CK7. RACEMASE. CEA M. IMM RECUT. NEG CONT. RECUT.\r\nIntraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGN/ cD. MESENTERY OVERLYING RIGHT ANTERIOR KIDNEY TUMORI. BENIGN FIBROUS TISSUE. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: SP: ANTERIOR GEROTA FASCIA. PERMANENT DIAGNOSIS: SAME.", "prediction": "-immunology-protein-immunop\u00a0protein-total\u00a0immunop-protein\u00a0protein\u00a0total\u00a0retin-1-protein total\u00a0protein targeted\u00a0immunoprevin-immun\u00a0immunologyology-rat\u00a0immun\u00a0phop\u00a0total\u2009protein\u00a0we\u00a0immun-protein\u2009protein-1\u00a0protein\u2009immunop\u2009protein\u2009total\u00a0cell\u00a0immunot\u00a0immunologically-immunologically targeted-drug-targeted-immunologic-proteinop-drug\u00a0immunotherapeutic-protein kinase-protein and\u00a0retretinology-immunoprene-protein,\u00a0\u00a0immunologic\u00a0\u00a0\u00a0total-protein\u202fprotein\u00a0\u00a0un\u00a0protein\u202fimmun\u00a0\u00a0ph\u00a0\u00a0we-immunotr\u00a0\u00a0drug-immunother\u00a0\u00a0in\u00a0\u00a01\u00a0\u00a0cell-immun-immun\u2009protein \u00a0\u00a0Western\u00a0immun\u202fprotein-\u00a0\u00a0\u2009\u00a0\u00a0targeted\u00a0protein kinase\u00a0\u00a0other\u00a0immunotoxin-protein gene\u00a0\u00a0-\u00a0immunimmunology\u00a0\u00a0\u00a0proteinology-Western\u00a0protein, total-cell\u00a0protein gene-immunotoxin\u00a0\u00a0gen\u00a0immun\u2009immun\u00a0Western-immunimmun\u00a0drug\u00a0\u00a0protein-Western-proteinology\u00a0immunotr"}
{"slide_id": "TCGA-BH-A18T-01Z-00-DX1.90123A74-F631-4538-AB2E-4076486ADF88", "reference": "The pathology report describes a patient who underwent a right segmental mastectomy and sentinel node biopsy. The final diagnosis reveals infiltrating ductal carcinoma and separate foci of ductal carcinoma in situ. The carcinoma is poorly differentiated with a Nottingham score of 9/9. Lymphovascular invasion is identified, and the ductal carcinoma in situ extends close to the posterior surgical margin of resection. All surgical margins of resection are free of tumor, and the non-neoplastic breast has fibrocytic changes. The sentinel lymph nodes and non-sentinel lymph node biopsy are negative for tumor. The report also includes an estrogen/progesterone and HER-2/neu assay. The DAKO HERCEPTEST reveals a weak to moderate complete membrane staining in over 10% of the tumor cells, interpreted as weakly positive with a score of 2+. A confirmation test for Her2/neu will be subsequently reported. Cytokeratin (AE1/3) stains have been performed to confirm the negative status of the sentinel lymph nodes.", "prediction": " total-immunology-1-mer-human total\u00a0human-human-1\u00a0human\u00a0immunop\u00a0\u00a0\u00a0immunology\u00a0\u00a01-human\u00a0\u00a0ph\u00a0\u00a0mer\u00a0immun\u00a0\u00a0human \u00a0\u00a0total\u00a0immunologic\u00a0\u00a0cell\u00a0\u00a0-\u00a0\u00a0protein\u00a0\u00a05\u00a0\u00a0sp\u00a0\u00a0other\u00a0\u00a07\u00a0\u00a0trans\u00a0\u00a0du\u00a0immunologically-immunologic-protein-protein targeted-immunologically total cancer-targeted-1 total urinary-immunotrogen-protein\u00a0du-drug-immunone-drug to\u00a0\u00a0drug-1 and\u00a0\u00a0pr\u00a0\u00a0in\u00a0\u00a0targeted-\u00a01\u00a0\u00a0we\u00a0other-\u00a0immunother\u00a0immunotr\u00a0\u00a03-\u00a0protein-\u00a0ph-\u00a0otherologic-\u00a0we-immun\u00a0otherother\u00a01 targeted\u00a0\u00a04\u00a0\u00a0un\u00a0\u00a0omb\u00a0\u00a02\u00a0\u00a0\u202f\u00a0\u00a0clinically\u00a0\u00a0(\u00a0\u00a0gen\u00a0\u00a0ology-immun-immunotherology-\u00a0spotr\u00a01\u2009\u00a0\u00a0\u00a0\u00a00\u00a0\u00a0otr\u00a0immun-\u00a0duology-du\u00a0\u00a0genome\u00a0\u00a0\u2009\u00a0immun \u00a0dumer-\u00a0cell-\u00a0targeted\u00a0"}
{"slide_id": "TCGA-A2-A4RX-01Z-00-DX1.E2C96C9D-5023-4F41-8CC8-24C6E015B252", "reference": "The pathology report describes a specimen consisting of right axillary sentinel nodes and a right breast mass. The lymph nodes were negative for malignancy on routine and immunohistochemical stains. The breast mass was a mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) with a malignant sarcomatous component, histologic grade 3, poorly differentiated, and sized 2.5 cm. The margins were negative, and lymph nodes were examined in parts A and B, which were negative for malignancy. The breast specimen also had ductal carcinoma in situ, high nuclear grade with central necrosis, and multifocal tumors with three foci. The largest, most dominant mass was considered for staging, grade, and scoring. The ER and PR were weakly positive, whereas Her-2 neu was negative. Three lymph nodes were sampled, all negative for metastasis. The gross description of the specimen and its sectioning into multiple cassettes with different stains for each cassette was detailed.", "prediction": "\u00a0immunology-protein\u00a0nanop\u00a0immunop\u00a0protein\u00a0immun\u00a0nan\u00a0protein\u2009nanop\u2009protein\u00a0\u00a0\u00a0immunoen\u00a0protein-immunop\u2009nan\u00a0dec\u00a0\u00a0cell\u00a0immun\u2009protein-protein\u2009\u00a0\u00a0nanot\u00a0\u00a0decop\u00a0\u00a0ret\u00a0immunoprevin\u00a0\u00a0more\u00a0nan-immun\u00a0\u00a0v\u00a0protein\u202fprotein\u00a0phop\u00a0ret\u2009protein\u2009immunop-protein-v\u00a0dec\u2009dec\u00a0decin\u00a0nan\u2009decop\u2009dec\u2009nan-protein\u202fdec\u00a0nanoform\u00a0\u00a0\u00a0cellop\u00a0cell\u2009\u00a0immun\u202fprotein\u2009\u2009\u00a0nanotr\u00a0\u00a0terminal\u00a0\u00a0pro\u00a0\u00a03\u00a0\u00a0ph\u00a0\u00a0vin\u00a0immuncell\u00a0\u00a0\u2009\u00a0\u2009immun\u00a0cell\u202f\u00a0\u00a0drug\u00a0\u00a0we\u00a0immunimmun\u00a0immun-\u00a0\u00a0ne\u00a0\u00a0total\u00a0\u00a0d\u00a0\u00a0proteinvin\u00a0protein\u2005\u00a0\u00a0Western\u00a0immunotr\u00a0immunprotein\u00a0\u2009\u2009protein\u202f\u00a0immunvin\u00a0\u2009\u2009\u00a0\u00a0\u00a0-\u00a0immun immun\u00a0\u00a0activity\u00a0\u00a07\u00a0\u00a0s\u00a0\u00a0gen\u00a0\u00a04\u00a0\u00a0qu\u00a0\u00a0is\u00a0\u00a0\u202f\u00a0proteinvin\u2009\u00a0pro\u2009\u00a0vin\u2009"}
{"slide_id": "TCGA-BH-A0E7-01Z-00-DX1.7FEE54C4-3795-403C-85B9-FF932BE56788", "reference": "Pathology report summary: The left breast segmental biopsy identified invasive ductal carcinoma with micro papillary features and ductal carcinoma in-situ. The tumor measured 2.1 x 1.8 x 1.3 cm with about 10% of micro papillary carcinoma. No prominent angiolymphatic invasion was observed. The margins were free of invasive and in situ carcinoma, but the closest margin was 1mm from the tumor. Fibrocystic changes with ductal epithelial hyperplasia were identified, and microcalcifications were observed in benign epithelium and arterial wall. The axillary dissection contents revealed metastatic tumor in one of the seventeen lymph nodes. The metastatic carcinoma measured 1.2x0.8 cm with extracapsular spread. The estrogen receptor and progesterone receptor were positive, while HER-2/neu was negative.", "prediction": " total-immunology-protein-1-human-human\u00a0human-1\u00a0protein-human total\u00a0immunology\u00a0\u00a0\u00a0immunop\u00a01\u00a0\u00a0human\u00a0immunologic\u00a0\u00a0pr\u00a0\u00a0other\u00a0\u00a01-\u00a0\u00a0protein\u00a0\u00a0cell\u00a0\u00a0ph\u00a0\u00a0du\u00a0\u00a0-\u00a0immun\u00a0\u00a0we\u00a0immunother\u00a0du-protein targeted-immunologic-targeted-drug-protein\u00a0immunot\u00a0in\u00a0drug-gen-1 to total cancer-immunop-gen\u00a0immunotr\u00a0dugen-immun\u00a0du            \u00a0\u00a0targeted-protein and\u00a0\u00a0total\u00a0\u00a05\u00a0\u00a0to\u00a0\u00a07\u00a0\u00a0drug\u00a0\u00a0sp\u00a0\u00a0un\u00a0ph-\u00a0other-\u00a0pr-\u00a01\u2009-\u00a0protein \u00a0\u00a0gen\u00a0\u00a0otr\u00a0\u00a0ne\u00a0\u00a0\u2009\u00a0\u00a0\u202fimmun\u00a0otherother\u00a0prpr\u00a0other\u202f\u00a0\u00a03\u00a0\u00a0in-\u00a0phother\u00a0immun-\u00a0dupr\u00a01 \u00a0other\u2009\u00a0du\u2009\u00a0protein\u2009\u00a0phph\u00a0otherape\u00a0\u00a04\u00a0\u00a0trans\u00a0\u00a0tum\u00a0\u00a0omb\u00a0\u00a0genome\u00a0\u00a08\u00a0\u00a0mer\u00a0\u00a0clinically\u00a0\u00a00\u00a0\u00a0duction\u00a0\u00a0(\u00a0"}
{"slide_id": "TCGA-AO-A12A-01Z-00-DX1.4E9609A7-9AAD-40A8-8344-8369DF998006", "reference": "A 1-year-old female presented with a right breast mass and core biopsy showing invasive ductal carcinoma, poorly differentiated. The patient underwent total mastectomy and sentinel lymph node biopsies. Histological examination revealed invasive ductal carcinoma measuring 3.1 cm with ductal carcinoma in situ also identified, constituting <= 25% of the total tumor mass. The invasive carcinoma is located in the upper outer quadrant, and no involvement of the nipple or skin is identified. Biopsy site changes and fibrocystic changes with apocrine metaplasia, microcalcifications, and columnar cell alteration without atypia are observed in the non-neoplastic breast tissue. Benign lymph nodes are identified in sentinel node biopsies, with additional sections ordered for deeper recuts and special stains. The results of special stains for ER, PR, and HER2/neu are positive, negative, and negative, respectively. Microscopic clusters of metastatic carcinoma measuring less than 2mm are identified in one sentinel lymph node. Intraoperative consultation confirmed all lymph nodes as benign.", "prediction": "1-human total-immunology-protein-1-mer-human\u00a0human-human-1\u00a0\u00a0total\u00a0immunologic\u00a0\u00a0\u00a0immunology\u00a0\u00a01\u00a0total-1 total\u00a0\u00a0protein\u00a0\u00a0human\u00a0immunop\u00a0\u00a03\u00a0\u00a0targeted\u00a0\u00a0(\u00a0\u00a0pre-mer\u00a01-1 greater greater\u00a0\u00a05\u00a0\u00a0in\u00a0\u00a07\u00a0\u00a0mer\u00a0\u00a0ph\u00a0\u00a0gen\u00a0\u00a0du\u00a0immunologically targeted-immunologic total urinary-protein targeted\u00a0(1-drug-gen1-targeted-human urinary-gen\u00a01 to greater\u00a0(3-mer1- and\u00a0\u00a0other\u00a0\u00a02\u00a0\u00a0pr\u00a0\u00a0we\u00a0\u00a0-\u00a0\u00a04\u00a0\u00a0sp\u00a0\u00a0clinically\u00a0\u00a0house\u00a0\u00a0\u00a0immunother\u00a0immun\u00a0\u00a0un\u00a0\u00a00\u00a0\u00a0drug-1\u2009\u00a0\u00a0pe\u00a0\u00a0trans\u00a0\u00a0end\u00a0\u00a0or\u00a0\u00a0genome-immun\u00a0protein-targeted\u00a03-immun-immunotherologic\u00a0immun-protein\u00a0immunotr\u00a0\u00a0 and\u00a0immunimmunologic-\u00a0targetedologic\u00a0(4-mermer-immun(1\u00a0targeted-immunimmunologyologicologic\u00a0targeted-1"}
{"slide_id": "TCGA-BH-A208-01Z-00-DX1.C7A2885D-0535-4506-B06E-82BC62D6DFE9", "reference": "Diagnosis: Invasive ductal carcinoma with poorly differentiated intermediate nuclear grade, massive vascular permeation including nipple, and fibrocystic changes. Three out of fifteen axillary lymph nodes positive for metastatic tumor with capsular and extracapsular extension. Previous reports indicate left mastectomy due to neiltrating ductal carcinoma, not otherwise specified.", "prediction": "-immunology-protein-immunop\u00a0house\u00a0immunology\u00a0house-human-human total-human\u00a0immunop-1-protein total\u00a0ununun\u00a0immunun\u00a0un\u00a0phun\u00a0protein-1\u00a0immun\u00a0immunologic\u00a0immun-immun\u00a0\u00a0\u00a0immunotroro-protein\u00a0\u00a0ph\u00a0un-ph\u00a0immunone-immunologic-immunologically targeted-house-immunotop-gen-protein/human-immunone/human\u00a0human-1 total or total cancer- or greater\u00a0immunologically-immunoma-immunun-immun-phop\u00a0\u00a01\u00a0\u00a0total\u00a0\u00a0du\u00a0\u00a0protein\u00a0-\u00a0\u00a0un\u202fun\u00a05\u00a0\u00a0we\u00a0\u00a0-1\u202fimmun\u00a0protein \u00a0\u00a0house\u202fimmunology,\u00a0\u00a0end\u00a0\u00a0cell\u00a0\u00a07\u00a0\u00a0asc\u00a0\u00a03\u00a0\u00a0other\u00a0immunotr\u00a0\u00a0one\u00a0\u00a0Western\u00a0immunimmunologyology-un\u00a0\u00a04\u00a0\u00a0targeted\u00a0\u00a0polymer\u00a0\u00a0un\u00a0Western-immun\u2009\u00a0\u00a0(\u00a0\u00a00\u00a0\u00a05-immunimmun\u00a01-cell\u00a0immun.\u00a0\u00a0gen\u00a0\u00a0ology-immunotrun\u00a0-immun"}
{"slide_id": "TCGA-AO-A1KT-01Z-00-DX1.47878910-4359-4795-B0BB-FAC147C8D932", "reference": "The pathology report is for a patient with invasive ductal carcinoma (IDC) on core biopsy of the left breast. There were 10 specimens submitted for examination, including three sentinel lymph nodes in the left axilla. Sentinel node #1 contained a microscopic cluster of tumor cells (<0.2mm) within a capsular lymphatic vessel, while sentinel nodes #2 and #3 were benign. The left breast mass was found to contain invasive ductal carcinoma, poorly differentiated with histologic grade III/III, measuring 1.9 cm, and focal ductal carcinoma in situ (DCIS). The DCIS constituted less than 25% of the total tumor mass and was present admixed with and adjacent to the invasive carcinoma. The HER2/neu gene amplification was not detected. All identified lymph nodes and tumor tissue were submitted for examination.", "prediction": "10-10-immunopmermermer-immunmer-human-human immunotroromer-1-mer-linear-1.1- or greater greater greater-than greater greater\u00a0than greater\u00a0immunopromer\u00a0un\u00a0immun. greater\u00a0human-1 greater greater urinary urinary-1 to greater greater than or greater\u00a0m.immunology-protein-immunotromer or greater cancer-matched, total cancer-protein to house house-1, house-m.\u00a0immunologically targeted-protein\u00a0protein-house-1\u00a0m- or\u00a0\u00a0immun\u00a0\u00a0\u00a01\u00a0immunology\u00a0\u00a0un\u202fun\u00a0\u00a05\u00a0\u00a0to\u00a0\u00a0protein\u00a0\u00a07\u00a0\u00a0total\u00a0\u00a0-\u00a0\u00a010\u00a0\u00a0cell\u00a0\u00a03\u00a0\u00a0end\u00a0\u00a0house\u00a0\u00a0ph\u00a0\u00a0mer\u00a0\u00a0Western\u00a0immunologic\u00a0\u00a0spun\u00a01-immun\u00a07-immun-un\u00a0un-\u00a0immunun\u00a0-5\u00a0immunotr\u00a0\u00a0com\u00a0\u00a02\u00a0\u00a04\u00a0\u00a0du\u00a0\u00a0asc\u00a0\u00a0is\u00a0\u00a0 or\u00a0immun immun\u00a0\u00a0art\u00a0\u00a06\u00a0\u00a0targeted\u00a0\u00a0trans\u00a0\u00a0\u00a0unmer\u00a0immun"}
{"slide_id": "TCGA-GM-A2DF-01Z-00-DX1.CD0BE6D7-2DB3-4193-84CC-F9BE7BF18CC2", "reference": "The pathology report describes a left breast biopsy in a patient with invasive ductal carcinoma and associated lymphocytic infiltrate. The largest focus of invasive carcinoma is 1.2 cm in the greatest dimension in the medial aspect of the specimen, with multiple satellite foci. Ductal carcinoma in situ extends over a 4 cm area, approaching the final inferior margin. Metastatic carcinoma is identified in one of thirty lymph nodes. The report includes gross descriptions and serial sections submitted for various tissue samples. Immunohistochemistry results show negative estrogen and progesterone receptors and negative HER-2/neu overexpression. The HER-2/neu gene levels are evaluated by FISH and demonstrate no amplification.", "prediction": " total-immunology-protein-human-human total\u00a0human\u00a0immunop\u00a0immunology\u00a0immun\u00a0\u00a0\u00a0human-1-human\u00a0\u00a0ph\u00a0immunologic\u00a0\u00a01\u00a0\u00a0cell\u00a0\u00a0total\u00a0\u00a0protein\u00a0\u00a0un\u00a0phph\u00a0\u00a0other\u00a0\u00a0in\u00a0\u00a0-\u00a0\u00a0immunot\u00a0\u00a0rat\u00a0\u00a0du\u00a0ph-immunologic targeted-immunologically targeted\u00a0immunologically-targeted-drug-protein total cancer-immunop-protein\u00a0immunotr\u00a0in-drug\u00a0immunotherapeutic-immun\u00a0protein-targeted\u00a0\u00a0pr\u00a0\u00a05\u00a0\u00a0drug-1\u00a0other-\u00a0protein \u00a0\u00a07\u00a0\u00a0we\u00a0\u00a0targeted-\u00a01-\u00a0immun-\u00a0pr-\u00a0in\u2009\u00a0\u00a0gen\u00a0\u00a0at\u00a0\u00a03\u00a0\u00a0to\u00a0\u00a0end\u00a0\u00a0clinically\u00a0du-immun-immunother\u00a0protein\u2009\u00a0otherother\u00a0phother\u00a0du\u2009\u00a0immunimmun\u00a0otherology-\u00a0photr\u00a0\u00a0omb\u00a0\u00a0wild\u00a0\u00a0tum\u00a0\u00a0trans\u00a0\u00a04\u00a0\u00a0Western\u00a0\u00a0otr\u00a0immunomb\u00a0immun\u2009\u00a0duology-immunimmunologic-\u00a0duph\u00a0phology\u00a0\u00a0(\u00a0\u00a00\u00a0"}
{"slide_id": "TCGA-EB-A97M-01Z-00-DX1.631C79E5-6973-4BA2-A4B3-E57B3991851A", "reference": "Summary: There is a skin lesion measuring 8x4 cm with a pigmented mass measuring 2x1.5 cm invading into the fatty tissue. Microscopic examination of the lesion shows malignant melanoma with ulceration, Clark's level IV, and a Breslow depth of 15 mm. The tumor is uninvolved at the margins and there is no evidence of lymphatic or venous invasion. The histologic grade is undifferentiated and no evidence of neo-adjuvant treatment is present.", "prediction": " and total\u00a0in\u00a0total\u00a0total- and\u00a0immunologic and preoperative preoperative\u00a0\u00a0\u00a0tot\u00a0\u00a0ep\u00a0total and greater\u00a0\u00a0up\u00a0\u00a0in fully\u00a0in human\u00a0\u00a0prin\u00a0\u00a0human\u00a0\u00a0un\u00a0\u00a0total,\u00a0\u00a0immunop\u00a0\u00a0 and\u00a0\u00a0terminal\u00a0\u00a0du\u00a0\u00a0\u2011\u00a0\u00a0com\u00a0\u00a0pre\u00a0\u00a0mer\u00a0\u00a0hen\u00a0\u00a0-\u00a0\u00a0            \u00a0\u00a0 greater\u00a0total fully\u00a0\u00a0 fully\u00a0 and human fully\u00a0total human\u00a0in completely\u00a0\u00a0to\u00a0\u00a0null\u00a0\u00a0 approximately\u00a0\u00a0 human\u00a0tot fully\u00a0\u2011 human\u00a0\u2011 and human\u00a0total Korean\u00a0\u00a0\u2009\u00a0\u00a0\u00a0\u00a0pathologic\u00a0\u00a03\u00a0\u00a0+\u00a0\u00a0oper\u00a0\u00a0end\u00a0\u00a0prof\u00a0\u00a0pro\u00a0\u00a0 preoperative\u00a0in clinically\u00a0\u00a0clinically\u00a0\u00a0targeted\u00a0\u00a05\u00a0\u00a0gen\u00a0\u00a0at\u00a0\u00a0a\u00a0\u00a0drug\u00a0\u00a0is\u00a0\u00a0ph\u00a0\u00a0op\u00a0in preoperative\u00a0total preoperative\u00a0terminal preoperative\u00a0 and preoperative\u00a0immunoper\u00a0in disease\u00a0\u00a0and\u00a0\u00a0protein\u00a0\u00a0s\u00a0\u00a0port\u00a0\u00a0intermediate\u00a0\u00a0 disease\u00a0epin\u00a0ep preoperative\u00a0comin\u00a0terminal-\u00a0compr\u00a0in Korean\u00a0in clinical\u00a0in-"}
{"slide_id": "TCGA-YG-AA3N-01Z-00-DX1.21350D99-44EB-42AF-83F8-90A059952FE4", "reference": "SUMMARY:\r\n\r\nA skin biopsy labeled as \"right chest, Skin melanoma\" was received for examination, measuring 6 x 3 x 0.7 cm. The lesion was identified as a malignant melanoma, nodular type, with a Clark level IV and 6mm in depth. Mitotic index was observed at 1/ mm\u00b2, lymph-vascular invasion was not identified, tumor-infiltrating lymphocytes were present, and ulceration was identified. The margins of the specimen were free of tumor. Additionally, two sentinel lymph nodes labeled as right axillary sentinel lymph node #1 and left axillary sentinel lymph node #2 were received for examination, and both were negative for metastasis. Immunoperoxidase stains for HMB45 and S-100 were done and reported as negative. Pathologic staging was indicated as pT4b pNo pMx.", "prediction": " total\u00a0in\u00a0human total-human \u00a0\u00a0\u00a0prin\u00a0\u00a0total\u00a0\u00a01\u00a0\u00a0human\u00a0human-human\u00a0\u00a0immun\u00a0\u00a0mer\u00a0\u00a0-\u00a0\u00a05\u00a0total- human\u00a0\u00a0pent\u00a0\u00a0            \u00a0\u00a03\u00a0\u00a0drug\u00a0\u00a0 human\u00a0pr\u00a0\u00a0other\u00a0\u00a0clinically\u00a0\u00a0pre-mer\u00a0prpr\u00a0in total complete\u00a0\u00a0\u2009\u00a0\u00a0genome\u00a0\u00a0(\u00a0\u00a0sp\u00a0\u00a0 total surgical\u00a0\u00a0in human total human-immunologic complete complete complete human to human\u00a0in complete human- and\u00a0\u00a0tot\u00a0\u00a0ur\u00a0\u00a0du\u00a0\u00a0 or\u00a0\u00a07\u00a0\u00a0more\u00a0\u00a0compar\u00a0\u00a0terminal\u00a0\u00a0cell\u00a0\u00a0\u202f\u00a0\u00a0protein\u00a0\u00a0targeted\u00a0\u00a0pathologic\u00a0\u00a0+\u00a0\u00a04\u00a0\u00a0at\u00a0\u00a08\u00a0\u00a0trans\u00a0\u00a0fer\u00a0\u00a0gen\u00a0\u00a0tum\u00a0\u00a0ph\u00a0\u00a0otr\u00a0\u00a0meric\u00a0\u00a0we\u00a0\u00a0end\u00a0\u00a0less\u00a0\u00a0a\u00a0\u00a0ne\u00a0\u00a0 pharmacologic\u00a0\u00a0 and\u00a0immunologic\u00a0\u00a0c\u00a0\u00a0ep\u00a0pr-in\u00a0protr\u00a0in disease\u00a0\u00a0 equal\u00a0\u00a0pe\u00a0\u00a0 biologic\u00a0\u00a0\u200a\u00a0\u00a0com\u00a0\u00a0 disease\u00a0"}
{"slide_id": "TCGA-FY-A76V-01Z-00-DX1.A7793C02-5EFE-4125-897E-ADAD1A6AF039", "reference": "The report describes the case of a male patient who underwent a total thyroidectomy due to the presence of multiple thyroid tumors. The tumors were primarily located on the right lobe and isthmus, and the largest tumor measured at 3.1 cm x 1.5 cm x 1.1 cm. One of the tumors was identified as a papillary carcinoma with a follicular variant, accounting for less than 99% of the tumor. The tumors did not invade the surrounding tissues, lymphovascular spaces, or nerves. The histologic grade of the tumor was well differentiated, and its capsule remained intact. The surgical margin of the specimen was uninvolved by carcinoma, and the closest margin had a distance of less than 1 mm from the invasive carcinoma. No malignant cells were observed in the right inferior parathyroid gland that was also resected during surgery. The PTNM stage was pT2NX.", "prediction": "\u00a0protein\u00a0immunop\u00a0nanop\u00a0ph\u00a0cell\u00a0immunology-protein\u00a0\u00a0\u00a0immun\u00a0nan\u00a0protein\u2009\u00a0\u00a0cell-cell\u00a0decop\u00a0\u00a0dec\u00a0\u00a0ph\u2009nanop\u2009\u2009\u00a0cell\u2009\u00a0immun\u2009\u00a0protein-\u00a0\u00a0\u2009\u00a0dec            \u00a0\u00a0more\u00a0dec\u2009nan\u00a0\u00a0ret\u00a0immun-protein\u2009\u2009protein\u00a0phop\u00a0dec-decop\u2009dec\u00a0decin\u00a0\u00a0protein\u202f\u00a0\u00a0v\u00a0decor\u00a0\u00a03\u00a0\u00a07\u00a0\u00a0pro\u00a0\u00a010\u00a0cellop\u2009\u00a0\u2009cell\u00a0\u00a0\u00a0cell\u202fdec\u00a0nan\u2009\u2009cell\u2009dec\u2009\u00a0nan-protein-immun\u00a0\u00a05\u00a0\u00a0T\u00a0\u00a0we\u00a0\u00a0-\u2009\u00a0\u00a0\u00a0\u202fprotein\u00a0\u2009immun\u00a0immun\u202f\u00a0\u2009\u2009\u00a0we\u2009\u2009\u2009\u00a0immuncell\u00a0\u2009ph\u00a0\u00a0drug\u00a0\u00a0Trans\u00a0\u00a0Western\u00a0\u00a0pr\u00a0\u00a0total\u00a0\u00a04\u00a0\u2009\u2009immun\u2009\u2009ph\u2009\u00a03\u2009\u00a0\u202f\u2009\u00a0more\u2009\u00a0-\u00a0\u2009\u202f\u00a0immunimmun\u00a0\u2009-\u00a0protein\u202f\u00a0cellcell\u00a0we\u202f\u00a0\u202f\u00a0\u2009\u2009\u202f\u00a0\u2009we\u00a0\u2009protein"}
{"slide_id": "TCGA-D8-A1XU-01Z-00-DX1.769DBC38-6F0D-425B-A904-79EBA1C119EF", "reference": "Histopathological examination was conducted on a total organ resection of the left breast. The clinical diagnosis was bifocal cancer of the left breast, and a simple mastectomy was performed. Results of the immunohistochemical examination showed estrogen receptors in over 75% of neoplastic cell nuclei, progesterone receptors in 10-75% of neoplastic cell nuclei, and HER2 protein stained negatively in invasive cancerous cells. Macroscopic description revealed Carcinoma ductale bifocale - NHG2. Carcinoma ductale in situ (DCIS) was observed in the tumors. There was also an invasion of carcinomatosa vasorum and in situ lesion of the type cancerisatio lobulorum. The histopathological diagnosis is invasive bifocal ductal carcinoma and carcinoma in situ of the left breast (NHG2, pTic, pNO (SN)), with vascular invasion. Compliance is valid.", "prediction": " total\u00a0cell\u00a0\u00a0\u00a0ph\u00a0\u00a0sp\u00a0\u00a0un\u00a0\u00a0end\u00a0\u00a07\u00a0more\u00a0sp-1-cell\u00a0-\u00a0\u00a01\u00a0\u00a0to\u00a0\u00a0men\u00a0\u00a0-\u2009\u00a0\u00a05\u00a0\u00a0immunop\u00a0\u00a0~\u00a0\u00a0house\u00a0\u00a0m\u00a0\u00a0d\u00a0\u00a0\u2011\u00a0\u00a0health\u00a0\u00a0dec\u00a0\u00a010\u00a0\u00a0protein\u00a0\u00a0drug\u00a0\u00a0ce\u00a0\u00a0gen\u00a0\u00a0than\u00a0\u00a0sect\u00a0\u00a0du\u00a0\u00a0mon\u00a0\u00a0more-\u00a0immun\u00a0\u00a0\u223c\u00a0\u00a08\u00a0\u00a0nm\u00a0\u00a0cell- or\u00a0\u00a0\u202f\u00a0\u00a0\u2009\u00a0cell to\u00a0-1\u00a0drug- or \u00a0\u00a0race\u00a0\u00a03\u00a0\u00a0ne\u00a0\u00a06\u00a0\u00a0targeted\u00a0\u00a04\u00a0\u00a0we\u00a0\u00a0is\u00a0\u00a0tum\u00a0\u00a0poly\u00a0\u00a0op\u00a0\u202f\u202f\u00a0sp\u202f\u00a0\u202f-\u00a0\u202f7\u00a0\u00a0otr\u00a0\u00a0molecule\u00a0\u00a0trans\u00a0\u00a0\u00a0\u00a0com\u00a0\u00a02\u00a0\u00a00\u00a0\u00a0mer\u00a0\u00a0cr\u00a0\u00a0ep\u00a0\u00a0c\u00a0\u00a0 or\u00a0\u2009sp\u00a0\u2009-\u00a07\u202f\u00a07\u2009\u00a0\u202fsp\u00a0\u202f5\u00a0\u2009\u2009\u00a0sp\u2009\u00a0\u2009\u202f\u00a0\u20097\u00a0\u20095\u00a0\u202f\u2009"}
{"slide_id": "TCGA-E2-A1IH-01Z-00-DX1.816F0C54-D87E-4E23-891B-98169F5B439B", "reference": "The pathology report describes the specimens received for analysis, including two lymph nodes from the left axilla, a left breast mass with needle localization, and an additional margin from the left breast. The left breast mass specimen is further described as a 1.5cm invasive, lobular carcinoma with a grade 2 SBR, located in the upper inner quadrant. The surgical margins are negative for tumor. The report also includes synoptic reports for ER/PR results and HER2 results, indicating positivity for estrogen and progesterone receptors and equivocal HER2 amplification. The report mentions an attempt to conduct FISH for HER2 amplification, but the tissue did not remain on the slide for analysis. The final diagnosis indicates negative results for metastases in both lymph nodes. Overall, the report provides details on the size, location, and type of cancer present in the left breast, as well as information on the status of lymph nodes and hormone receptors.", "prediction": " total\u00a0in\u00a01\u00a0pr\u00a0\u00a0pr-1\u00a0\u00a0\u00a01-\u00a0\u00a0sp\u00a0\u00a0other\u00a0\u00a0drug-1-mer\u00a0\u00a0total\u00a0\u00a0pent\u00a0\u00a0compar\u00a0\u00a0ph\u00a0\u00a0+\u00a0\u00a05\u00a0\u00a0we\u00a0\u00a0clinically\u00a0\u00a0du\u00a0\u00a0cell\u00a0\u00a0\u2009\u00a0\u00a0trans\u00a0\u00a0duction\u00a0\u00a0(\u00a0\u00a0-\u00a0spur\u00a0\u00a03\u00a0\u00a0targeted\u00a0\u00a07\u00a0\u00a0c\u00a0\u00a0ne\u00a0\u00a0mer\u00a0other-in\u00a0\u00a0sequ\u00a0\u00a0ur\u00a0in- or\u00a0\u00a0more\u00a0\u00a0to\u00a0\u00a010\u00a0\u00a0end\u00a0\u00a04\u00a0\u00a0cycle-\u00a0prur\u00a0prpr-\u00a0neovascular\u00a0\u00a08\u00a0\u00a0terminal\u00a0\u00a0in\u2009\u00a0sp-\u00a01\u2009\u00a0pr\u2009\u00a0other\u2009-\u00a05-\u00a0we-\u00a0otherpr\u00a0spotr\u00a0\u00a0genome-\u00a0comparpr\u00a0prother\u00a0price\u00a0\u00a0protein\u00a0\u00a0gen\u00a0\u00a0or\u00a0\u00a0\u00a0\u00a0week-\u00a0trans-\u00a0dupr\u00a0-\u20091-prpr\u00a0neur\u00a0sppr\u00a0otherape\u00a0\u00a0            \u00a0\u00a0ther\u00a0\u00a0ct\u00a0\u00a0meric\u00a0\u00a0tum\u00a0\u00a0gn\u00a0\u00a0\u202f\u00a0\u00a0com\u00a0\u00a0otr"}
{"slide_id": "TCGA-AA-A03F-01Z-00-DX1.8E1A83FE-2C85-4444-A8FC-D0691817968A", "reference": "The pathology report describes a right hemicolectomy specimen with an ulcerated cecal carcinoma. The histological type of the carcinoma is a moderately differentiated, partially mucus-forming colorectal adenocarcinoma, which measures 5.5 cm in its largest diameter and subtotally encloses the cecum. Invasive tumor spread is observed into all intestinal wall layers as far as the mesocolic fatty tissue and subserosa. Colon mucosa is observed with some tubular adenomas with moderate epithelial dysplasia. The oral and aboral resection margins and greater omentum are tumor-free. Four out of twenty-nine regional lymph nodes are observed with metastases from the colon carcinoma. The tumor stage is determined to be pT3, pN2 (4/29), and G2.", "prediction": "\u00a0protein-protein-n-protein\u00a0nanoprobiln-decorquil-protein\u2009decorvin-n\u00a0decorprotein\u00a0moremoremorevin-decrvinvin-1-prodrug-decrob-decaperob-proprotein-decoprob-typemoremorequilpro-decin-decmoremorenan-decavil-decatmoremoredecin\u00a0decr10-protein fullyn-typen-provin-prodecopmorenanopnanop-decurvin-protein\u202fdecor-decilmoreququilprotein\u00a0dec\u00a0decopnanotrmorevinvin\u00a0dec-dec\u00a0quilmoremore\u00a0T-dec6-T-more\u00a0dec6\u00a0T\u00a0more\u00a0provin\u00a0pro\u00a0decil-pro-vin-6-decquiln\u00a0Til-4-dec8-dec5-dec-6\u00a0decT-4\u00a0morevin\u00a0nan\u00a0dec8\u00a0decapevin-nan-pro\u00a0protein\u00a0\u00a0dec4-vin\u00a0T1-dec4\u00a0decmore\u00a0more-decvin-8\u00a0pro-protein\u2005dec\u00a08\u00a0Tape\u00a0dec1-"}
{"slide_id": "TCGA-DX-A6BE-01Z-00-DX1.67FF80A5-340F-4709-8976-A2A1FCF16BA9", "reference": "The pathology report concerns a case of retroperitoneal mass in the left kidney and adrenal gland, likely sarcoma. The patient underwent radical resection, nephrectomy, and adrenalectomy, which resulted in the identification of a dedifferentiated liposarcoma with a highly malignant spindle cell sarcoma component, a well-differentiated liposarcoma component, and a background of lipoma-like and sclerosing type. The tumor measured 21cm. The spleen was also removed and weighed 152g, with no significant pathological changes. The report provides detailed gross descriptions of the specimens, including ureter measurements, arterial margins, adrenal gland measurements, and multiple masses with different surfaces and colors. Representative sections of the mass were submitted for TPS and culture, while photographs were also taken. The summary of sections shows that there were sections of adipose tissue around the kidney, normal kidney tissue, well-differentiated, myxoid areas, poorly differentiated areas, and margins. The summary also shows that the splenic capsule was gray-tan, nodular, and glistening, with a hemorrhagic and disrupted hilar area containing areas of blood clot.", "prediction": "-protein-to-1-ph\u00a0ph\u00a0retret-1\u00a0more\u00a0sp- or\u00a0~\u00a0sp\u00a0ret- or\u2009\u00a0\u00a0\u00a0more-more-than\u00a0\u00a0ph-ph-\u00a0\u00a0un\u00a0phop- or or\u00a0\u00a0ret\u00a0\u00a0-\u00a0ph\u2009ph\u00a0\u00a0to\u00a0\u00a07\u00a0\u00a0cell\u00a0\u00a0du\u00a0\u00a0~\u2009-\u00a07-drug- or greater-more\u00a0more than\u00a0more disease-protein\u00a0\u00a0drug-more or disease-more total\u00a0more or greater\u00a0\u00a0than\u00a0~-ph\u2009\u00a0phph- or to\u00a0retmore-sp\u00a0\u00a05\u00a0\u00a0we\u00a0\u00a0dec\u00a0\u00a0\u2009\u00a07\u2009\u2009\u00a0sp\u2009\u00a05\u202f\u00a0\u00a03\u00a0\u00a0qu\u00a0\u00a0\u2011\u00a0\u00a0spotr\u00a0\u00a0otr\u00a07\u202f\u00a0ph\u202f\u00a0\u2009-\u2009\u00a0\u20097\u00a0\u2009sp\u00a0\u202fph\u00a05\u2009\u00a0cell-\u00a0\u202f\u00a0\u202f7\u00a0\u202f\u202f\u00a0sp\u202f\u00a05-cell\u00a0photr\u00a0\u20095\u00a0\u2009\u20097-cell-7\u2009\u00a0we\u2009\u00a0\u202f\u2009\u00a03\u2009\u00a0-\u202f\u00a03-\u00a0\u2009\u202f\u00a0we\u202f\u00a0qu\u2009\u00a0protein-\u00a05"}
{"slide_id": "TCGA-J4-A6G1-01Z-00-DX1.CB849D80-60EA-407B-87AB-B3161ABC0A6F", "reference": "The pathology report pertains to a patient who underwent a radical prostatectomy for prostate cancer and also had an umbilical hernia. The report includes the following information. The adipose tissue anterior to the prostate and three pelvic lymph nodes (two on the left, one on the right) did not show any malignancy. The umbilical hernia was successfully identified and consists of fibroadipose tissue. The prostate and seminal vesicles weighed 40 grams, measured 5 x 4 x 3 cm, and displayed adenocarcinoma with a Gleason score of 8/10. The tumor site was bilateral and mostly present in the peripheral zone, with invasion into extraprostatic soft tissue on one side. The extent of tumor involvement was more than 50% of the examined tissue. No carcinoma was seen at any margins, seminal vesicles, or lymph nodes. However, perineural invasion was present. No treatment effect on the carcinoma was identified. The TNM staging was pT3a, pNo, pMX. Additionally, extensive acute and chronic prostatitis were observed.", "prediction": " total\u00a0in\u00a0human\u00a0human-human total-human\u00a0immunology-human-1\u00a0\u00a0\u00a0total\u00a0\u00a0immun\u00a0immunologic\u00a0\u00a01\u00a0total-immun\u00a0\u00a0protein\u00a0\u00a0mer\u00a0\u00a0human \u00a0\u00a0cell\u00a0\u00a0other\u00a0\u00a0-\u00a0\u00a0ph\u00a0immunop human\u00a0\u00a0clinically\u00a0\u00a0du\u00a0immun immun\u00a0\u00a0drug\u00a0\u00a0ur\u00a0immun-immunologic total urinary-protein-human urinary total targeted-1-drug-1 total human-immunology total surgical to human-protein total greater\u00a0\u00a05\u00a0\u00a0more\u00a0\u00a0pr\u00a0\u00a0            \u00a0\u00a0sp\u00a0\u00a0otr\u00a0\u00a0\u2009\u00a0\u00a0\u202f\u00a0\u00a0in-\u00a0immunother\u00a0immunotr\u00a0other-\u00a01-\u00a0protein-immun-protein\u00a0other\u2009\u00a0immunologically\u00a0\u00a0(\u00a0\u00a0\u00a0\u00a0terminal\u00a0\u00a0we\u00a0\u00a0pathologic\u00a0\u00a03\u00a0\u00a0trans\u00a0\u00a0targeted\u00a0\u00a0less\u00a0\u00a0omb\u00a0\u00a0gen\u00a0\u00a0wild\u00a0\u00a0tum\u00a0\u00a0genome\u00a0\u00a0vin\u00a0\u00a04\u00a0immunimmunologic-immunotherologic\u00a0protein trans\u00a0immun disease-immunimmunology\u00a0\u00a00\u00a0\u00a0pos\u00a0\u00a0 \u00a0immunomb\u00a0immun "}
